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The Sertoli Cell-Spermatid Junctional Complex: A Potential Avenue For Male 
Contraception 
 
Katja M. Wolski 
ABSTRACT 
  
 The Sertoli cell ectoplasmic specialization is a specialized domain of the calcium-
dependent Sertoli-spermatid adherens junction.  Structurally abnormal or absent Sertoli 
ectoplasmic specializations are associated with spermatid sloughing and subsequent 
oligospermia in conditions associated with reduced fertility potential, although the 
junctional strength between these cells is not known.  Adjudin is a potential male 
contraceptive agent thought to interrupt testicular binding dynamics of adherens 
junctions, resulting in controlled spermatid sloughing.   
 It was hypothesized that the mechanism of action of Adjudin, pertinent to its 
putative contraceptive effect, is the disruption of the Sertoli cell-spermatid junction.  This 
was tested in vitro using primary isolates of germ cells and both primary and immortal 
Sertoli cells.   
This dissertation presents the examination of Sertoli-germ cell interactions in 
three parts, which address the overall aims of this dissertation project: (1) measurement 
of the junctional strength between Sertoli cells and spermatids in vitro, (2) determination 
of the efficacy of sk Sertoli cell lines in Sertoli-germ cell binding studies in vitro, and (3) 
assessment of Adjudin as a potential male contraceptive, by measuring the junctional 
binding strength between Sertoli cells and spermatids exposed to this chemical in vitro.   
  2 
For the first time, the strength of the Sertoli-spermatid junction has been 
measured, using a micropipette pressure transducing system (MPTS).  Results reported 
in this dissertation demonstrate that the junctional strength between Sertoli cells and 
germ cells can be measured in vitro, support long held speculations regarding Sertoli-
spermatid junctional interactions, and provide a technology to test proposed 
mechanisms of junctional binding dynamics between cells of the seminiferous epithelium 
(Chapter 2).  Although the sk cell lines initially expressed mRNA for the FSH receptor, 
coculture results determined that these cell lines have limited value for investigating 
Sertoli-germ cell binding dynamics in vitro (Chapter 3).  By utilizing the MPTS and 
primary cell isolates, Adjudin was determined to reduce the junctional strength between 
Sertoli cells and step-8 spermatids.  In conclusion, results support the use of Adjudin as 
a potential reversible male contraceptive agent by a mechanism which alters the 
adhesion properties between the step-8 spermatid and the Sertoli cell (Chapter 4).   
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CHAPTER 1 
Background 
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Spermatogenesis 
The complicated process of spermatogenesis occurs throughout the reproductive 
life of the male.  It is a remarkable process requiring many cellular, molecular, and 
biochemical events, in which diploid spermatogonia undergo division, chromosome 
reduction, and extensive morphological differentiation to result in haploid elongated 
spermatozoa [1, 2].  This process occurs in the seminiferous tubules of the testis, within 
the seminiferous epithelium – the cellular “lining” of the seminiferous tubule – which 
consists of the developing germ cells and the fixed population of Sertoli cells.  The 
seminiferous epithelium is divided into two compartments – the basal and adluminal 
compartments – by the blood-testis barrier (see Sertoli Cells below).  It is here that the 
male contribution to the perpetuation of all mammalian species begins. 
Spermatogenesis can be divided into three stages, producing upward of 150 x 
106 spermatozoa per day per man [3].  In stage one, the stem cell-like spermatogonia 
residing in the basal compartment either self-proliferate or undergo mitosis to give rise to 
spermatocytes.  After entering meiosis and reaching the preleptotene/leptotene stage, 
these spermatocytes must migrate through the blood-testis barrier to the adluminal 
compartment.  Stage two occurs as these spermatocytes continue through meiosis to 
result in round spermatids, which then enter stage three, a process identified as 
spermiogenesis, wherein no cell division occurs, only morphological cell differentiation.  
The goal of spermiogenesis is to turn round spermatids into elongated spermatids with 
condensed nuclear material (i.e., spermatozoa), which are then released into the lumen 
of the seminiferous tubule at spermiation.  To reach this goal, many temporal and spatial 
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mechanisms occur.  These include the crossing of the germ cells through the 
seminiferous epithelium, signaling events, and other interactions between the Sertoli 
cells and the germ cells during this epithelial translocation, collectively referred to as the 
“guiding hand” in the formation and disassembly of the Sertoli-germ cell junctions,  
However, there is limited understanding of the mechanisms involved in 
spermatogenesis. 
 At any given point in time, several generations of germ cells develop 
concurrently in the seminiferous tubule of the mammalian testis [4].  The seminiferous 
epithelium has been subdivided into various spermatogenic stages, in which new and 
old generations of germ cells are undergoing the spermatogenic process in close 
association with the Sertoli cells [4].  The seminiferous epithelial cycle is, therefore, 
made up of various stages in which new generations of germ cells are connected to 
older generations.  Their development is coordinated via the presence of fixed cellular 
associations [4, 5].  A seminiferous epithelial cycle in the rat consists of 14 stages, 
identified by the unique morphology of the developing germ cells [5-7], and extends over 
12 – 14 days.  It takes a total of ~4.5 epithelial cycles, i.e., ~58 days, for a single 
spermatogonium to differentiate into 256 spermatozoa.  At each stage, at least four 
different germ cells are present in the seminiferous epithelium.  In the human, this cycle 
has six stages and extends over 16 days with 70 – 74 days required for completion of 
spermatogenesis [8, 9].   
Hormonal control of spermatogenesis   
The hormonal control of spermatogenesis begins before birth and continues 
through puberty and adulthood.  This complex interplay within the hypothalmo-pituitary-
testicular axis is driven by hypothalamic gonadotrophin-releasing hormone (GnRH), 
which induces gonadotrophin [follicle stimulating hormone (FSH) and luteinizing 
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hormone (LH)] secretion from the pituitary.  Sertoli cells possess the FSH-receptor [10], 
whereas Leydig cells primarily express the LH receptor, though LH receptor staining has 
also been seen in spermatogenic cells [11].  In order to achieve full spermatogenic 
potential, both FSH and androgens are required.   
LH stimulates testosterone secretion by the Leydig cells in the testis, which 
promotes spermatogenesis.  FSH acts on the Sertoli cell, and while FSH has a key role 
in the development of the testis, a controversy over whether or not FSH is needed for 
adult spermatogenesis exists.  Control of gonadotrophin release involves negative 
feedback of testosterone on LH and FSH, as well as inhibin B on FSH.  Whereas an 
increase in testosterone reduces the amount of LH and FSH released from the pituitary, 
a decrease in inhibin B increases the amount of FSH released [12] 
Four main steps comprise the effects of hormones on spermatogenesis: (1) the 
proliferation and differentiation of spermatogonia, (2) the development of spermatocytes, 
(3) spermiogenesis, and (4) spermiation.  Strong evidence exists for the regulation of 
spermatogonial development by FSH through the prevention of apoptosis [13].  
Moreover, testosterone requires the presence of FSH in order to influence the 
development of spermatocytes [14].  The prevention of apoptosis by exposure to FSH is 
also important in normal spermatocyte development in the rat [15], whereas in the 
human, spermatocytes still appear to enter meiosis upon withdrawal of FSH [16].  Acute 
withdrawal of FSH induces the apoptosis of round spermatids in the rat [13, 15, 17], and 
a chronic lack of testosterone causes spermatid sloughing, identified as a loss of 
adhesion between Sertoli cells and round spermatids [18].  However, in the human, no 
evidence exists to indicate that FSH is necessary for fertility, in that no large decrease in 
the number of spermiogenic cells is seen [16], and the number of round spermatids seen 
in the ejaculate (i.e., spermatid sloughing) of FSH-deficient men is relatively low, 
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therefore not accounting for the profound fall in sperm count [19].  Perhaps more 
important in the human is the retention of elongated spermatids in the seminiferous 
epithelium upon withdrawal of FSH [16, 20], as is also seen to some degree in the rat 
(reduction of spermiation by 15%) [21].   
Hormonal disruption of spermatogenesis   
In the adult, withdrawal of gonadotrophins stops sperm production, in the human 
halting at the spermatogonial stage [16], and in the rat at the primary spermatocyte 
stage [22].  It is clear that the key regulators of spermatogenesis and junctional 
dynamics in the seminiferous epithelium are FSH and testosterone [23-25].  Cameron 
and Muffly [26] showed maximal binding of round spermatids to Sertoli cells in vitro in 
the presence of FSH and testosterone.  It appears that FSH regulates the Sertoli cell 
cytoskeleton associated with the Sertoli-germ cell junctions [27], while testosterone 
implements the adhesion process of round spermatids at these junctions [18].  It is 
proposed that testosterone also promotes and maintains the maturation of round 
spermatids in the rat [22].  The withdrawal of testosterone has been shown to result in 
the detachment of round spermatids (i.e. spermatid sloughing) between stages VII and 
VIII [18], the time when the Sertoli-spermatid junctional complex forms [28].  When both 
FSH and testosterone are withdrawn, spermatogenesis is severely affected [21, 29], 
which includes disruption of the Sertoli cell junctional dynamics within the seminiferous 
epithelium.  A more detailed description of the roles of FSH, androgens, and estrogens 
on spermatogenesis is presented in Appendix 1. 
Sertoli cells 
Without the support of Sertoli cells, spermatogenesis could not be completed.  
The extensive functions of these cells include (1) providing structural support for the 
germ cells, (2) aiding in the translocation of the germ cells, (3) secreting many trophic 
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factors and nutrients for the germ cells, (4) phagocytosing dead/damaged germ cells, (5) 
forming the blood testis barrier (in part to define the polarity of the seminiferous 
epithelium and in part to create immunity), and other essential functions in 
spermatogenesis [30-35].   
The Sertoli cell was discovered in 1865 by Enrico Sertoli and is also known as 
the “nurse cell” of the seminiferous epithelium.  It is a tall, columnar, polar cell extending 
from the base to the lumen of the seminiferous tubule, with many cytoplasmic crypt-like 
extensions due to the reshaping of the cell by germ cells [28, 35-37].  They occupy 
approximately 17 – 19% of the volume in the seminiferous epithelium of the adult rat [38, 
39].  Each Sertoli cell nurtures and protects anywhere from 30 to 50 germ cells [39, 40] 
at various stages of development.  Around postnatal day 20 in the rat, Sertoli cells cease 
proliferation, and this crucial fixed number determines the amount of germ cells that will 
normally develop in spermatogenesis.   
Some authors classify Sertoli cells into two categories: type A and type B [35-37].  
Type A Sertoli cells are classified by the presence of mature spermatids wedged deep 
within Sertoli cell cytoplasmic crypts, whereas type B Sertoli cells are classified as 
having none or few, barely visible cytoplasmic crypts.  In this context, type A Sertoli cells 
are thought to transform themselves into type B Sertoli cells in the course of a 
seminiferous epithelium cycle.  These changes are understood to be necessary in order 
to support the developing germ cells and their movement through the seminiferous 
epithelium. 
Sertoli cell cytoskeleton 
 Sertoli cells support developing germ cells physically by depositing extracellular 
matrix and by forming specialized cell junctions between themselves and germ cells in 
various stages of differentiation.  The well-developed cytoskeleton of the Sertoli cell is 
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essential in maintaining the collective organization of the seminiferous epithelium [7, 28, 
36, 41], in part, by (1) maintaining the shape of the cell; (2) stabilizing the cell membrane 
at sites of contact; (3) positioning, securing, and aiding in the movement of germ cells; 
(4) arranging and transporting organelles within the cell; and (5) participating in the 
release of mature spermatids from the seminiferous epithelium.  Three major 
components – actin, intermediate filaments, and microtubules – make up the 
cytoskeleton and exhibit unique distribution patterns in each stage of the seminiferous 
epithelial cycle [35, 41, 42].   
Actin plays a very important role in maintaining Sertoli cell structure and in 
providing the cell with properties of cell contractility.  It also is thought to participate in 
motility-related processes, since it is found at sites of cell contact at the periphery of the 
Sertoli cell.  Actin filaments are chief components of ectoplasmic specializations (see 
Ectoplasmic Specialization below) and tubulobulbar complexes, which exist between the 
Sertoli cell and germ cells in various stages of differentiation.   
Intermediate filaments are found at the desmosome-like junctions between 
Sertoli cells and between Sertoli cells and spermatocytes/round spermatids [43].  The 
precise role of intermediate filaments in the Sertoli cell is not yet known, but their 
distribution indicates they play a part in retaining the integrity of the seminiferous 
epithelium [44, 45].  
The role of microtubules in the Sertoli cell is much clearer than that of 
intermediate filaments.  They participate in (1) the preservation of the cell’s columnar 
shape; (2) the translocation of spermatids in the seminiferous epithelium; (3) the 
movement of intracellular organelles; and (4) the alteration of the cell membrane to the 
nearby spermatid heads [37, 41].  Microtubules are found at the ectoplasmic 
specialization [46, 47] and the most remarkable changes in the organization of 
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microtubules occurs as mature spermatids associate with Sertoli cell ectoplasmic 
specializations [48].   
While these cytoskeletal components have been associated with the events of 
germ cell movement, the precise mechanisms underlying the regulation of the 
cytoskeleton during the different epithelial stages and in the movement of germ cells 
remains a mystery. 
Blood-testis barrier 
 The blood-testis barrier, formed by a unique junctional complex between 
adjacent Sertoli cells, divides the seminiferous epithelium into a basal and an adluminal 
compartment [review [49]].  It serves as an immunological barrier for the highly antigenic 
adluminal compartment germ cells and in doing so creates a specialized adluminal 
environment for these germ cells.  This is accomplished, in part, by controlling the 
passage of molecules between the two epithelial compartments [review [49]].  This 
dynamic barrier is comparable in strength to the blood-brain barrier.  However, the 
blood-testis barrier must periodically “open” to allow the passage of germ cells from the 
basal to the adluminal compartment of the seminiferous epithelium, requiring 
disassembly and assembly of cell-cell junctions by mechanisms which are still unclear.  
The mechanisms for the formation and regulation of the blood-testis barrier are also 
unknown, though gonadotrophins have been suggested to play a role, as have cytokines 
and growth factors [50, 51]. 
Two important findings led to the development of the concept of the blood-testis 
barrier: (1) the radical differences in the composition of fluids and proteins obtained from 
the rete testis and seminiferous tubule lumen when compared to those of the testicular 
lymph and blood plasma [52] and (2) the variations in the rate in which radioactive 
tracers and dyes passed from the blood plasma to testicular fluids [53-59].  However, 
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concrete evidence for this barrier did not exist until the studies of Dym and Fawcett [60], 
who established its unique ultrastructure and its ability to occlude intercellular tracers, 
such as lanthanum. 
The specialized environment created by the blood-testis barrier is crucial to germ 
cell development.  Sertoli cells produce, secrete, and efficiently distribute products into 
the adluminal compartment, created by the blood-testis barrier, essential for growth and 
differentiation of the adluminal germ cells [32, 61-65].  Not only do these tight junctions 
limit the movement of nutrients and wastes into and out of the adluminal compartment, 
they deny adluminal access to immunoglobulins and lymphocytes [66], thereby creating 
a unique sequestered space for spermatids [67].  Since foreign antigens reside on the 
surface of these haploid germ cells, without the blood-testis barrier the body’s immune 
system would recognize them and reject them.   
Recently, the blood-testis barrier and the Sertoli cell tight junctions have been 
divided into two finer physiological distinctions – the occluding zonule and the occluding 
macule [68] – based on the actuality that in vivo, the assembly of the blood-testis barrier 
and the Sertoli cell tight junctions are not synchronous events [69-71].  The occluding 
zonule divides the seminiferous epithelium into its two compartments and is the basis of 
the blood-testis barrier.  Formed at 15 – 18 days of age in the rat, the fibers composing 
this zonule are continuous and form an impervious barrier [72, 73].  In contrast, the 
occluding macule is a focal seal through which interstitial fluids or tracers can easily 
pass.  The fibrils composing the macule are discontinuous and situated immediately 
above and below the occluding zonule [69-71]. 
Sertoli cell-germ cell junctions  
There are two types of intercellular junctions between germ cells and Sertoli 
cells: (1) anchoring junctions and (2) gap communicating junctions.  Both types are 
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believed to play crucial roles in spermatogenesis.  Up- and down-regulation of these 
junctions occurs during spermatogenesis and the process of germ cell migration from 
the basal to the adluminal epithelial compartments [74].  However, the regulation of 
these junctions and their role in the completion of spermatogenesis is not yet fully 
understood.  
Anchoring junctions 
Four types of anchoring junctions exist between Sertoli and germ cells: (1) cell-
cell actin based adherens junctions; (2) cell-matrix actin-based focal contacts; (3) cell-
cell intermediate filament-based desmosomes; and (4) cell-matrix intermediate filament 
hemidesmosomes.  All anchoring junctions link the cytoskeleton of one cell to another 
cell or to the extracellular matrix, in order to maintain tissue integrity [75], however, each 
of these is biochemically and structurally different from one another.  Recent reports 
have suggested that these junctions also play a role in signal transduction [76-78].   
Adherens junctions.  Four protein complexes are identified with the actin based 
adhesion of adherens junctions: (1) cadherin-catenin; (2) nectin-afadin-ponsin; (3) 
integrin-laminin; and (4) vezatin-myosin [79] (Figure 1.1).  Of these, three (1-3) have 
been found in the testis [79].  Two modified forms of the adherens junction are found in 
the testis – the ectoplasmic specialization and the tubulobulbar complex, which will be 
discussed later. 
Cadherin-catenin complex.  The best studied adherens junction proteins in the 
testis have been the cadherins.  These 115 – 140 kDa transmembrane proteins consist 
of two cytoplasmic domains, one transmembrane domain, and five calcium-binding 
domains (EC1 – 5, with the most conserved region being a His-Ala-Val cell adhesion 
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Figure 1.1. Schematic illustration showing the molecular architecture of the Sertoli-germ cell 
adherens junction [68].   
recognition sequence [80] found within the EC1 domain) and bind homotypically with 
cadherins in adjacent cells in a calcium dependent manner [81-85].  The cytoplasmic 
domain binds to intracellular proteins, which is important in clustering cadherins to form 
functional anchoring junctions and in transmitting information from the cell surface to the 
nucleus to activate genes that maintain the integrity of the epithelium [81-84, 86].   
The binding of the cytoplasmic domain of cadherins to either ß- or ?-catenin 
(plakoglobin) is crucial to its function [85-88].  This cadherin-catenin complex is linked 
indirectly to the actin cytoskeleton by a-catenin [89].  ß-catenin is also stimulated by the 
Wnt signal transduction pathway as a transcriptional cofactor [90-92].  Colocalization of 
ß-catenin with ezrin, which links the cell membrane and the actin cytoskeleton [93], and 
TGF-ß type II receptor [94], suggests a link between TGF-ß1 and adherens junction 
dynamics [94].  Another catenin, p120ctn has been identified as a putative Src-substrate 
critical to cadherin-mediated cell adhesion.  One study indicates that p120ctn induces the 
clustering of E-cadherin [95], and in response to growth factors, such as EGF, this 
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catenin is phosphorylated on its tyrosine and serine residues, thereby entering the 
nucleus to interact with Kaiso, a newly identified transcription factor [96].  Though the 
interaction between E-cadherin and ß-catenin is required to begin the cascade of events 
leading to cell adhesion, it is the interaction between E-cadherin and p120ctn that is 
necessary for the formation of stable adherens junctions [97].  Changes in the 
phosphorylation of p120ctn also affect cell adhesion [98].  Tighter cell adhesion is 
associated with a decrease in phosphorylation and loss of adhesion is associated with 
an increase in phosphorylation [98, 99].   
The regulation of cadherin-catenin may be related to the GTPases.  RhoA, Rac1, 
and Cdc 42, all members of the GTPase family, have been shown to localize with the 
cadherin-catenin complex [100, 101].  Also, the over expression of p120ctn is thought to 
elicit an increase in cell motility via Rho GTPases [102, 103].  During junction assembly, 
E-cadherin and ß-catenin have been shown to be internalized and then recycled back to 
the cell membrane via Rab5 [104, 105], a member of the GTPase family.  Tyrosine 
phosphorylation of ß- and/or ?-catenin has been shown to result in the loss of cadherin-
catenin mediated cell adhesion [106-108].   
Though the presence of adherens junctions in the testis have been demonstrated 
[28, 49, 72], their structure and function are poorly understood.  The actin based cell-cell 
adherens junction between the Sertoli cell and the germ cell in the mammalian testis is 
important not only in mechanical adhesion of the cells, but also in the morphogenesis 
and differentiation of the germ cells.  Turnover of these calcium dependent junctions 
occurs during the process of germ cell migration from the basal to the adluminal 
epithelial compartments [74].  However, their role in completion of spermatogenesis is 
not yet fully understood.   
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Both Sertoli cells and germ cells have cadherin/catenin complexes as identified 
by immunohistochemical analysis of related intracellular molecules such as N-cadherin, 
E-cadherin, a-catenin, ß-catenin, ?-catenin, and p120ctn [47, 109-113].  The N-
cadherin/catenin complex has been shown to regulate cell adhesive function between 
Sertoli cells and germ cells [114].  The presence of cadherins and catenins has been 
identified in isolated Sertoli and germ cells via immunoprecipitation and immunoblotting.  
N-cadherin has been detected by Western blot analysis in the plasma membranes of 
both Sertoli cells and spermatogenic cells [114].  Lee et al [113] have detected N- and E-
cadherin in Sertoli and germ cells via semiquantitative reverse transcription-polymerase 
chain reaction (RT-PCR) and immunoblotting.  During the assembly of adherens 
junctions between Sertoli cells and germ cells, Lee et al [113] observed a transient 
induction in the steady-state mRNA and protein levels of cadherins and catenins, 
indicating that the cadherin/catenin complex may be a functional unit of the Sertoli-
spermatid junctional complex.  Isolated germ cells have been shown to possess E-
cadherin and ß-catenin in an almost equimolar ratio of 1:1 to that which occurs in Sertoli 
cells [113].  This suggests that both Sertoli and germ cells contain the cadherin/catenin 
complex, thereby interacting with each other in a homotypic fashion.  However, it has not 
yet been localized directly to the ectoplasmic specialization.   
Studies using cross-linking and immunoprecipitation in isolated seminiferous 
tubules and in Sertoli-germ cell cocultures show the N-cadherin-catenin complex 
attaching to the actin cytoskeleton [113].  This finding was in direct contrast to that of two 
previous studies, in which this complex was found to be associated with intermediate 
filaments [114, 115].  It is also possible that an intermediate filament based cadherin-
catenin complex does exist, e.g., at the intermediate filament based desmosome, and is 
used in adhering developing germ cells to Sertoli cells.  However, a thorough study of 
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desmosome proteins has not yet been conducted in the testis, although the results of 
such a study would be useful in order to delineate the composition of desmosome-like 
junctions in the testis.   
At least 25 different cadherins have been identified in the testis by RT-PCR [114].  
Each cadherin demonstrates a stage-specific staining pattern.  For example, N-cadherin 
is seen to be localized at: (a) the basal inter-Sertoli junctions, (b) Sertoli-spermatocyte 
junctions, and (c) Sertoli-elongated spermatid junctions at spermatogenic stages I 
through VII [47].  N-cadherin immunostaining has been observed in and/or around the 
heads of elongated spermatids in spermatogenic stage VIII that was less intense 
following spermiation [110].  However, in these studies of N-cadherin, specific 
localization was not clear, and its localization to the ectoplasmic specialization could not 
be substantiated by subsequent studies in this lab or others.  Abnormally retained 
spermatids at spermatogenic stage IX also have shown positive immunostaining for N-
cadherin around the heads of elongated spermatids [47], whereas in a recent study by 
Beardsley and O’Donnell [116], abnormally retained spermatids did not show N-cadherin 
immunostaining in or around the heads, but it was present in the remaining residual 
bodies.  However, Mulholland et al [115] and Johnson and Boekelheide [117] have not 
observed cadherin staining in relation to ectoplasmic specializations and deny the idea 
that N-cadherin, or any cadherins, are present at the ectoplasmic specialization.  In 
these studies, N-cadherin has been found to be at the site of spermatocyte adhesion to 
the Sertoli cell.  Coimmunoprecipitation and chemical cross-linking experiments by Lee 
et al [113] have shown that Sertoli cell N-cadherin interacts with actin and vimentin.  
Unfortunately, in vivo studies of such proteins are near impossible because mutations in 
N- or E-cadherin are lethal in the early stages of development [118-120].   
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N-cadherins are located in the Sertoli-germ cell junctional complex, and 
immunoneutralization of N-cadherin results in a reduction in spermatid adhesion [121].  
Perryman et al [121] and Lampa et al [122] have shown that follicle stimulating hormone 
(FSH) and testosterone control N-cadherin expression and spermatid binding.  
Moreover, upregulation of N-cadherin mRNA has also been seen in isolated Sertoli cells 
when exposed to FSH and estrogen [123]. 
Immunohistochemical studies have localized ß-catenin and p120ctn to the luminal 
edge of spermatogenic stage VII and VIII tubules [47] and p120ctn at Sertoli-Sertoli 
junctions, as well as at sites of Sertoli cell-elongated spermatid contact [112].  After 
spermiation, ß-catenin relocalizes to a more basal position around groups of elongated 
spermatids [47].  N-cadherin antisera coprecipitates ß-catenin [47, 110, 113] and p120ctn  
[47] before and after spermiation, and ß-catenin antisera coprecipitates N-cadherin [47, 
113] and p120ctn [47].  Finally, recent findings have suggested a necessary role of ß-
catenin in the activity of N-cadherin related to signal transduction within the Sertoli cell 
[74, 109]. 
Nectin-afadin-ponsin complex.  The nectin-afadin-ponsin complex has also 
been reported to be present at adherens junctions between Sertoli cells and round 
spermatids [124].  The calcium-independent cell adhesion protein nectin consists of one 
transmembrane domain, one cytoplasmic domain, and three Ig-like extracellular 
domains [125, 126].  Four nectins have been identified [127, 128], all of which have two 
or three splice variants (except nectin-4) [124-127, 129-133], and mediate cell adhesion 
by binding either homo- or heterotypically with another nectin on the adjacent cell 
membrane [124, 127, 133-135].   
In the testis, Northern blots have identified weak expression of nectins-1 and -4, 
moderate expression of nectin-2, and strong expression of nectin-3 [127, 133].  Nectin-3 
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is almost exclusively expressed by spermatids [136].  Nectin-2 is found in Sertoli cells, 
germ cells, and Leydig cells [136].  Nectin-2d is found at adhesion sites between Sertoli 
cells and elongated spermatids, colocalizing with F-actin at what appears to be the 
ectoplasmic specialization (see Ectoplasmic Specialization below), with its highest levels 
at stages VI – VIII of spermatogenesis [137].  Nectin-2-/- mice show abnormal sperm 
morphology and infertility [137].  Because of these studies, it is possible that the nectin-
afadin-ponsin complex may induce cell-cell adhesion in the seminiferous epithelium via a 
heterotypic nectin-based interaction [136].   
Afadin, an F-actin binding protein, connects the cytoplasmic domain of nectin to 
the actin cytoskeleton [138, 139].  Two splicing variants of this molecule exist: 1-afadin, 
found ubiquitously in tissues, including cells of the testis, and s-afadin, found exclusively 
in cells of the brain [138, 139].  Recently it has been demonstrated that the entire binding 
site for 1-afadin is found on a-catenin [140], thereby giving rise to the idea of cross-talk 
between the cadherin-catenin protein and the nectin-afadin-ponsin complexes.  For the 
localization of the nectin-afadin-ponsin complex to the adherens junction, a-catenin is 
needed [141].   
Ponsin is a cytoplasmic protein that associates with 1-afadin [142] or vinculin 
[143-146].  As a result, vinculin may be the protein that links the cadherin-catenin and 
nectin-afadin-ponsin complexes to each other [142].  Very little is known about the 
function of ponsin, but its presence in the testis has been shown via Northern blots [142].   
Integrin complex.  Though the integrins a1 through a6 and ß1 through ß3 have 
been identified in the testis [115, 147, 148], the most studied of these is the integrin 
receptor a6ß1, which has been localized to the Sertoli cell-germ cell interface [115, 148-
150].  This location is interesting, in that the traditional role of integrins is in cell binding 
to the extracellular matrix at hemidesmisomes and focal adhesions, interacting with 
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collagens and laminins [review [151]], not at adherens junctions, joining two cells.  
Laminin is a known binding partner for a6ß1 integrin [152], and it is the ?3 laminin chain 
(of laminin 12) that has been localized to the adluminal compartment of the seminiferous 
epithelium [153], thereby suggesting that laminin ?3 is a putative binding partner for 
a6ß1 integrin at the Sertoli-spermatid adherens junction.  The a6ß1 integrin is also 
thought to be involved in signaling events in the Sertoli cell via integrin-linked kinase 
[115].   
Integrins in the Sertoli cell convey bidirectional signals, prompting events such as 
tyrosine phosphorylation [154-156], activating downstream signal transducers, such as 
Rho GTPase and focal adhesion kinase (FAK), which affect cell adhesion [157, 158].  
For example, integrins at the apical Sertoli-spermatid ectoplasmic specialization are 
partially regulated by the integrin/ROCK (Rho-associated protein kinase)/LIM (Lin-11, Isl-
1, and Mec-3 kinase)/cofilin pathway [68, 157].  When cell-cell adhesion in the 
seminiferous epithelium was chemically perturbed using Adjudin (see Adjudin below), 
the proteins of this integrin/ROCK/LIM/cofilin pathway were shown to be upregulated, 
with changes in their phosphorylation status [159, 160].  In addition, when rats were 
pretreated with a ROCK inhibitor, the effects of Adjudin on the disruption of cell-cell 
adhesion were delayed [157].  Moreover, Adjudin has been shown to alter the 
integrin/FAK/phosphatidylinositol 3 (PI 3)-kinase/p130 Cas/ERK signaling pathway [158].   
Integrins also play a role in the signaling events associated with extracellular 
matrix remodeling and cell movement [161], involving cycles of cell adhesion and de-
adhesion [162, 163].  Several kinases that are found at the ectoplasmic specialization 
have been identified in the process of integrin-mediated cell signaling, including FAK 
[115, 158], Csk [47], integrin-linked kinase (ILK) [115], and Src [47, 158].   
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Ectoplasmic Specialization.  The ectoplasmic specialization is the unique 
cytoskeletal structure of the Sertoli cell that forms the principal component of the Sertoli-
spermatid adherens junction [31, 164, 165].  Abnormal or absent Sertoli ectoplasmic 
specializations have been associated with a reduction of mature sperm in semen [27, 
117, 166] and is thought to a major contributing factor in oligospermia [27, 167].  The 
morphology of these junctions has been well described, but the molecular composition of 
them still is not well understood. 
Ectoplasmic specializations are found basally in the Sertoli cell near Sertoli-
Sertoli tight junctions and between Sertoli cells and round (step-8) and elongating 
spermatids.  They consist of hexagonally packed bundles of actin filaments situated 
between the plasma membrane and a cistern of endoplasmic reticulum [168].  
Ectoplasmic specializations are important in cell-cell adhesion in the seminiferous 
epithelium and are dynamic structures that remodel during spermatogenesis.  The basal 
ectoplasmic specializations between Sertoli cells assemble and disassemble as germ 
cells move from the basal to the apical compartments of the seminiferous epithelium 
[review [7, 28, 150, 164, 168].  Apical ectoplasmic specializations are first seen in the rat 
at stage VIII of rat spermatogenesis, when the step-8 spermatid appears [164].  It is 
thought the ectoplasmic specialization forms in the Sertoli cell to strongly anchor the 
step-8 spermatid to the seminiferous epithelium [28, 164], since desmosome-like 
junctions no longer exist at this time between the Sertoli cell and the spermatid [28].  
However, until now, the actual strength of this junction has not been determined.  The 
ectoplasmic specialization is also thought to play a role in the positioning and the 
elongation of the spermatids, since throughout spermiogenesis, the ectoplasmic 
specializations remodel in adaptation to the morphological changes occurring to the 
spermatid heads in the Sertoli cell crypts [169-171].  The apical ectoplasmic 
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specialization is present until appropriate release of the step-19 spermatid [164], and 
inappropriate release of earlier stage spermatids (i.e., spermatid sloughing) is related to 
abnormal ectoplasmic specialization structure and oligospermia [18, 172].   
The best studied protein complex of the apical ectoplasmic specialization is the 
a6ß1 integrin [115, 147, 148], but a recent study has also suggested the presence of 
a4ß1 integrin [110].  The proteins existing at the basal ectoplasmic specializations are 
not as well characterized as those at the apical ectoplasmic specializations.  The nectin-
afadin-ponsin complex appears to be restricted to the apical ectoplasmic specializations 
[136], whereas the cadherin-catenin complex is largely found at basal ectoplasmic 
specializations [110, 113, 114].  However, N-cadherin has also been localized to the 
Sertoli-elongated spermatid junctions [47, 173], and N-cadherin immunostaining has 
been observed in and/or around the heads of elongated spermatids at stage VIII of 
spermatogenesis and was less intense following spermiation [110].  According to Wine 
et al [47], abnormally retained spermatids at stage IX of spermatogenesis also show 
positive immunostaining for N-cadherin around the heads of the elongated spermatids, 
but Beardsley and O’Donnell [116] maintain that abnormally retained spermatids do not 
show N-cadherin, whereas the remaining residual bodies do.  Mulholland et al [115] and 
Johnson and Boekelheide [117] contend that N-cadherin, or any other cadherins, are not 
present at the ectoplasmic specialization.  However, immunoneutralization of N-cadherin 
demonstrates a reduction in spermatid adhesion [121].  Immunohistochemistry has also 
localized ß-catenin and p120ctn to the luminal edge of tubules at stages VII and VIII of 
spermatogenesis [47, 112].  After spermiation, ß-catenin relocalizes to a more basal 
position around groups of elongated spermatids [47].  N-cadherin antisera also 
coprecipitates ß-catenin [47, 110, 113] and p120ctn before and after spermiation [47], 
while ß-catenin antisera coprecipitates N-cadherin [47, 113] and p120ctn [47].  Nectin-3 is 
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expressed in germ cells and heterotypically binds to nectin-2 on the Sertoli cell 
membrane [136].  Nectin-3 is reported to be restricted to sites of Sertoli cell-elongating 
spermatid interaction in stages VII and VIII of spermatogenesis [137].  Other proteins 
also are reported to provide functional contributions at the ectoplasmic specialization.  
These include actin [review [41]], a-actinin [[174], vinculin [175, 176], myosin VIIA [177], 
gelsolin [178], fimbrin [168], espin [179], paxillin [115], testin [180], integrin-linked kinase 
(ILK) [115], and Kelch-like neurofilament-E2-related molecule-associating protein 1 
(Keap1) [181, 182].  Keap 1 has been reported to be located at the ectoplasmic 
specialization [182], even though its binding partner, myosin VIIA [177], has not, 
indicating that Keap1 can associate with other molecules when at the ectoplasmic 
specialization.   
“Free” ectoplasmic specializations are also found within the Sertoli cell [7], 
though the significance of these remains unknown.  They may be part of left over 
attachment sites of adherens junctions not yet completely recycled. 
Espin.  Espin is an actin binding protein found in many organs but most 
abundantly in the testis [179], specifically the Sertoli cells, and shows no resemblance to 
other actin-binding proteins [183].  Espin in the seminiferous epithelium appears to be 
concentrated around the heads of spermatids from mid- to late spermiogenesis, as 
determined by immunoperoxidase immunocytochemistry [172, 179]; it is also seen near 
the base of the seminiferous tubules [179].  However, stages VI – VII of 
spermatogenesis demonstrate espin immunofluorescence primarily at the apical 
ectoplasmic specialization [68, 172, 179].  Sertoli cells surrounding step-8 spermatids, 
where an organized ectoplasmic specialization is first seen, demonstrate espin 
immunostaining in a C-shaped cap near the area where the spermatid meets the Sertoli 
cell [183].  This is not seen around step-7 spermatids [183].  Nearing spermiation, espin 
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immunostaining near the luminal edge of the seminiferous epithelium decreases and 
then disappears around the time of sperm release [172, 183].  This change in 
localization appears to reflect the disassembly of the ectoplasmic specialization [172, 
183].  Through immunogold electron microscopy, espin has been localized to the parallel 
bundles of actin filaments present at the ectoplasmic specialization in Sertoli cells [179].  
A smaller isoform of espin, termed “small espin,” has been seen associated with parallel 
actin bundles found in brush border microvilli in the kidney and intestine [184].  This 
further supports the hypothesis that espin is involved in the bundling of actin at the 
ectoplasmic specialization.   
Tubulobulbar Complexes.  The tubulobulbar complex is another modified 
adherens junction found between Sertoli cells at the level of the tight junction and 
between Sertoli cells and elongate spermatids that are ready for release into the tubule 
lumen [171, 185, 186].  This complex is a pair of tubular structures surrounded by actin, 
extending from the concave surface of the spermatid head [187].  It is believed 
tubulobulbar complexes aid in preventing the premature release of elongated spermatids 
[169], as well as remove cytoplasm from spermatids [185, 188], since in the presence of 
these complexes, the volume of cytoplasm is reduced by as much as 70% [185].  
Interestingly, unique to tubulobulbar complexes, the apical tubulobulbar complexes are 
not visible until a few days before spermiation, at stage VIII of spermatogenesis.  After 
spermiation, they are quickly internalized and degraded by the Sertoli cell [169, 187].  In 
contrast, basal tubulobulbar complexes form during stages II – V and are most abundant 
during stages  IV – V of spermatogenesis, while being least abundant at stages VI – VIII 
[41].  Each mature testicular spermatid can also contain 4 – 24 tubulobulbar complexes, 
thereby proposing a role in germ cell movement [185, 186].  They also may play a role in 
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the internalization of junctions during germ cell movement [166, 186, 189], since basal 
tubulobulbar complexes interact with tight and gap junctions [186]. 
Focal Contacts.  Also known as focal adhesions or adhesion plaques, these 
actin-based adhering junctions anchor cells to the extracellular matrix and are found in 
nearly every epithelia.  They are largely composed of integrins that connect the actin 
within the cell to the extracellular matrix.  These dynamic structures regulate cell 
movement and are known to participate in signal transduction [reviews [103, 190-194].  
This junction type has not been investigated in any depth in the testis, but proteins found 
at focal contacts are often also found at the ectoplasmic specialization.         
 Integrins, belonging to a family of aß heterodimeric transmembrane proteins, 
provide a physical link between the cell cytoskeleton and the extracellular matrix, as well 
as providing a mechanism to move signals bidirectionally across the plasma membrane 
to regulate many cell behaviors [151].  For example, in response to cell adhesion, 
integrin cytoplasmic-domain-associated protein-1 can be phosphorylated by protein 
kinase C (PKC), cAMP-/cGMP-dependent kinases, and calcium/calmodulin-dependent 
protein kinase II [195].   
The adaptor protein vinculin is functionally related to a-catenin [196] and is found 
at focal contacts in several epithelia, as well as cell-cell anchoring junctions.  Vinculin is 
mostly found at the E-cadherin-catenin complex [197].  When vinculin expression was 
blocked in 3T3 cells, cell adhesion was disrupted and cell motility increased [198], 
whereas its overexpression decreased movement of the cell [199].  Vinculin, a substrate 
for tyrosine and serine/threonine protein kinases [200], can substitute for a-catenin in 
functional adherens junctions [197].  In the testis, this protein is found in both the apical 
and basal ectoplasmic specializations [175, 176] in the cytoplasm of the Sertoli cell [47, 
172]. 
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Another component of the focal contact is talin, which has actin-binding sites, as 
well as binding sites for focal adhesion kinase [201], phospholipids [202], vinculin [203], 
TES [204], and layilin [205].  Since talin can bind to the cytoplasmic tails of ß1, ß2, ß3, 
and ß7 integrins [206-209], talin and integrin together are required for focal adhesion 
assembly [210].  Cell adhesion and movement are disrupted when talin is blocked in 
fibroblasts and HeLa cells [211].  This protein is also found in the testis [212]. 
Desmosomes.  Desmosomes are cell-cell anchoring junctions that attach to 
intermediate filaments.  These highly organized spots between cells are situated 
between two plaques [review [213] which consist of two domains: (1) an extracellular 
core (desmoglea) and (2) several dense symmetrical cytoplasmic plaques that are 
parallel to the membrane.   
Three protein families make up the desmosome: (1) cadherins (desmocollins and 
desmogleins), (2) armadillo proteins, and (3) plakins (review [214]).  The desmosomal 
cadherins are connected to the intermediate filaments via proteins such as plakoglobin 
(?-catenin), desmoplakin, and plakophilin.  Plakoglobin is common to both desmosomes 
and adherens junctions [215].  Other proteins are also thought to play roles, including 
intermediate filaments and associated proteins (IFAP) 300 [216], desmocalmin [217], 
periplakin [218], envoplakin [218], plectin [219], and pinin [220].  Though desmosomes 
have been most extensively studied in the epidermis, their architecture in the testis, 
except for the presence of plakoglobin [113], remains unknown [review [28, 43]. 
Hemidesmosomes.  The hemidesmosome is found on the basal lamina in the 
testis, between the Sertoli cell and the basement membrane [221].  Similar to focal 
adhesions, these junctions connect the cytoskeleton of a cell to the basement 
membrane, but use intermediate filaments instead of actin.  Integrins are the only protein 
of the hemidesmosome that has been characterized, with ß4 integrin as crucial [review 
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[222].  In the early 1990s, a monoclonal antibody (1-2B7B) raised against a component 
of hemidesmisomes reacted with a protein that localized to the basement membrane of 
the testis [223].  To this day, this protein has yet to be identified.   
Gap communicating junctions 
 Gap communicating junctions allow the exchange of small molecules and ions 
between cells through intercellular channels formed by the noncovalent interaction of 
two hemichannels (connexons).  Each cell contributes a connexon, and the connexon is 
usually found clustered with other connexons to form a plaque.  These connexons are 
composed of six integral membrane subunits (connexins) that surround a hydrophilic 
pore [review [75, 224].   At last 20 connexins have been discovered in mammalian 
tissues [review [224]. 
Though the presence of gap communicating junctions between Sertoli cells has 
been known for several decades [60], it wasn’t until 1996 [225] that stage-specific 
expression of connexins was determined.  The best studied connexin, connexin43, is 
found at Sertoli cell gap junctions, which has the most intense staining detected during 
stages I – VIII of spermatogenesis, in addition to reported increases in staining intensity 
appearing during testicular development [226].  Other studies have shown that gap 
junctions exist between Sertoli cells and pachytene spermatocytes in vitro [227, 228].  
Connexin33 is also a testis-specific and expressed mainly in germ cells [74].  At least 13 
connexins have been identified thus far in the testis [229].   
Gap communicating junctions appear to mediate signals between Sertoli cell and 
germ cells, thereby indicating an important role in the development of spermatids in the 
seminiferous epithelium.   
Although a great deal has been learned about Sertoli cell junctions, especially 
from studies in vitro, these studies have all been accomplished almost entirely by using 
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primary cell isolates, limiting the practicability of these types of studies.  Although several 
Sertoli cell lines exist, one exhibiting the capability of binding spermatids would greatly 
expedite these types of studies.  A more detailed description of immortalized Sertoli cell 
lines is presented in Appendix 2. 
Male infertility and Adjudin 
A number of health-related conditions are associated with reduced fertility 
potential and oligospermia in men, including varicocele [230], hyperprolactinemia [231], 
diabetes [232], and idiopathic oligospermia [233].  These conditions all are associated 
with reduced sperm in the semen, i.e., oligospermia, and ultrastructural pathology 
unique to the junctional apparatus of the seminiferous epithelium [233].  Cap stage 
spermatids in the human (step-8 spermatids in the rat) are presumed to be tightly 
anchored to the seminiferous epithelium at a Sertoli cell adherens junction, which 
includes the unique Sertoli ectoplasmic specialization [31, 165].  In both in vitro and in 
vivo observations of experimental animal models, disruption of this junction resulted in 
spermatid sloughing and subsequent oligospermia [18, 117, 166, 172].  
 Due in part to both the lack of comprehension about the process and the 
complexity of spermatogenesis, the development of a safe, effective, and reversible 
(oral) contraceptive for men lags far behind that for women.  Currently all that is 
available to men in this form of contraception is the condom or abstinence.     
 Early attempts to develop a male oral contraceptive pill were based on using 
testosterone to turn off sperm production via signals from the brain [234], as is seen with 
the female oral contraceptive.  However, this has not been as successful as in the 
female and several side effects exist.  Other methods of hormone delivery, such as the 
patch, have also not been highly successful. 
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Lonidamine (1-[2,4-dichlorobenzyl]-indazole-3-carboxylic acid) is an anticancer 
drug that disrupts the respiratory process of cells with condensed mitochondria, such as 
cancer cells and spermatids [235, 236].  Lonidamine also causes vacuolation and 
retraction of apical cytoplasm in the Sertoli cell in the rat, thereby releasing germ cells 
into the lumen of the seminiferous epithelium [237].  However, at high doses, lonidamine 
is toxic and irreversible [159].  Therefore, in an effort to produce a safe male 
contraceptive, Cheng et al [159] developed two analogs to lonidamine – 1-(2,4-
dichlorobenzyl)-indazole-3-carbohydrazide (AF-2364, now known as Adjudin) and 1-
(2,4-dichlorobenzyl)-indazole-3-acrylic acid (AF-2785), both with the potential to be male 
contraceptives.   
Throughout recent years, it has been discovered that Adjudin is a better 
candidate for male contraception than AF-2785.  Essentially, administration of Adjudin 
depletes seminiferous tubules of germ cells [159, 160].  Studies have shown that this 
compound has little or no effect on organs not involved in reproduction [160], in that the 
metabolic processes of organs such as the liver, kidney and brain are left undisturbed 
with the administration of Adjudin.  By 24 – 48 hours >95% of Adjudin is removed from 
nearly all organs [238].  The hypothalamic-pituitary-testicular axis also appears to remain 
unaffected by Adjudin administration, in that negligible changes in serum FSH, LH and 
testosterone have been observed.   
The rapid depletion of round and elongating spermatids, and the consequent 
ultimate depletion of spermatocytes, occurred in the rat with a weekly treatment of 50 mg 
Adjudin/kg body weight (bw; via gavage) for five weeks [160].  Twenty-nine days after 
the initial dose of Adjudin, the fertility efficacy fell to zero and remained at 0% for up to 
90 days [160].  At 104 days post-treatment, fertility resumed, with 25% of the rats siring 
a normal litter size, and after 157 days, the fertility efficacy rose to 75% [160].  Only 25% 
  29 
of the rats remained infertile at 197 days (the last mating period) [160].  After only six 
days from the initial dose of Adjudin, many seminiferous tubules were found to be devoid 
of elongated spermatids, and structural disorganization was seen via prominent spaces 
within the germinal epithelium [160].  At 40 days after initial treatment, 98% of the 
seminiferous tubules were devoid of spermatocytes and spermatids [160].  The diameter 
of the seminiferous epithelium was reduced by 30%, and no apparent changes were 
seen in the interstitium of the testis [160].  Regeneration of the germinal epithelium 
began at 100 days post-treatment, and at 130 days post-treatment, normal 
spermatogenic activity was seen [160].  By 210 days post-treatment, 95% of the 
seminiferous tubules demonstrated normal morphology [160].  Testicular weight 
decreased by 70% until day 210 post-treatment [160]. 
Most vulnerable to Adjudin treatment is the site of the apical ectoplasmic 
specialization and tubulobulbar complexes [239].  The desmosome-like junctions 
between Sertoli cells and spermatids and spermatocytes are also affected [157, 158, 
239].  In as little as four hours after the administration of Adjudin (50 mg/kg bw, gavage), 
damage to the adherens junction between the Sertoli cell and spermatid was seen via 
electron microscopy [173], in that many distinct intercellular spaces existed, leading to 
spermatid sloughing.   
Lui et al [157] have determined that Adjudin initially activates the 
integrin/cadherin/testin protein complex at the site of the ectoplasmic specialization.  
Downstream activation by Adjudin then occurs in the integrin/ROCK/LIM kinase/cofilin 
[157] and integrin/FAK/PI 3-kinase/p130 Cas/MAP kinase pathways [158].  In other 
epithelia Adjudin has no effect on cell adhesion [157].  These data suggested that 
Adjudin works at the level of the ectoplasmic specialization.  A recent study confirmed 
this idea, in that it used a biotinylated UV-cross-linking analog of lonidamine (the parent 
  30 
compound of Adjudin) and showed that lonidamine bound tightly to actin stress fibers in 
Sertoli cells [240].  In addition, Adjudin may cause germ cell loss in the seminiferous 
epithelium by disrupting the homeostasis of proteases and protease inhibitors at sites of 
cell adhesion [241].  Siu et al [241] showed the Adjudin-induced spermatid sloughing 
involved the activation of metalloproteases (MMP).  MMP-2 and MMP-9 inhibitors delay 
the loss of elongating/elongate spermatids by Adjudin [241].  Further studies of Adjudin 
have demonstrated that the efficacy of this compound is quite poor when administered 
intramuscularly, as well as having a relatively low bioavailability when given by gavage in 
adult rats [238].  An important finding in the studies of Adjudin has been that only <7% of 
Adjudin administered orally is absorbed [238].  However, the dosage has been adjusted 
to induce effective and reversible infertility [238].  Doses of Adjudin at 37.5 – 50 mg/kg 
body weight every week for 2 – 3 doses via gavage are highly effective in inducing 
reversible infertility in male rats are [238], which is also maintained when given 
intraperitoneally but not intramuscularly.  The most effective course of administration of 
Adjudin is two doses at 50 mg/kg bw every week [238].  Two or more doses are 
possible, but it takes longer to regain fertility, and in some instances, only partial fertility 
is then achieved, due to a loss of spermatogonia [238].  The bioavailability of Adjudin 
was increased 2 -3 fold with micronized Adjudin at <53 µm particle size (i.e., 16 mg /kg 
bw versus 50 mg/kg bw) [238].  Though the bioavailability of this compound is low, it 
may still be an appropriate and effective contraceptive in the male [238].  It is apparent 
that the efficacy of Adjudin can be improved with a finer version of the micronized drug, 
perhaps at a particle size of <5 µm [238].  Even though the absorption is low, 
microionized Adjudin can be prepared and does increase the bioavailability [238].  
Currently, the understanding of the exact molecular mechanism by which Adjudin 
exerts its affects is limited.  The protein complex that acts as a receptor for Adjudin or is 
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targeted by this compound is unknown [238].  What is understood is that the first step of 
the process is the activation of the integrin/laminin complex and the subsequent 
downstream activation of either the RhoB/ROCK/LIM kinase/cofilin [157] or the FAK/PI 
3-kinase/p130Cas/MAP kinase pathway [242].  This results in a change in the 
polymerization/depolymerization of the actin cytoskeleton in the Sertoli cell, inducing 
spermatid sloughing [238].  Studies using androgen suppression-induced spermatid 
sloughing have also shown similar activation of protein kinases, as has been reported to 
occur after Adjudin administration [243].  Though the levels of N-cadherin and ß-catenin 
increased with the hormone suppression-induced spermatid sloughing (also reported to 
occur after the administration of Adjudin), tyrosine phosphorylation of ß-catenin 
increased, and the specific interaction between N-cadherin and ß-catenin decreased 
[243].  It has been suggested that this also may be a crucial mechanism for the action of 
Adjudin in spermatid sloughing [243].   
Specific aims and general hypothesis 
 To develop efficient and reversible contraceptives in the male by manipulating 
the spermatogenic process in a definable manner, one popular approach today is the 
targeted and controlled disruption of the junctional dynamics within the seminiferous 
epithelium, in particular the Sertoli cell-spermatid adherens junction.  The specific aims 
of this doctoral research were: (1) to measure the strength of junctions between germ 
cells and Sertoli cells in vitro and determine if the presence of the unique ectoplasmic 
specialization between Sertoli cells and step-8 spermatids actually results in an increase 
in the binding strength between these two cell types; (2) to determine if Sertoli cell lines 
(sk11, sk9, and sk11 TNUA5) are as effective as primary Sertoli cell isolates in Sertoli 
cell-spermatid binding studies in vitro; and (3) to determine if the potential contraceptive 
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agent Adjudin disrupts the junctional strength between the Sertoli cell and step-8 
spermatid in vitro. 
The specific aims of this dissertation project (Chapters 2 – 4) are based on the 
scientific prerequisite that potential contraceptive agent, such as Adjudin, can only be 
realized when its targeted mechanism of action, which in this case is the disruption of 
Sertoli-spermatid junctions, is clearly defined.  It is hypothesized that the mechanism of 
action of Adjudin, pertinent to its putative contraceptive effect, is the disruption of the 
Sertoli cell-spermatid junction. 
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ABSTRACT 
 
The Sertoli cell ectoplasmic specialization is a specialized domain of the calcium-
dependent Sertoli cell-spermatid junctional complex.  Its role is not only associated with 
the mechanical adhesion of the cells but also in the morphogenesis and differentiation of 
the developing germ cells.  Abnormal or absent Sertoli ectoplasmic specializations have 
been associated with step-8 spermatid sloughing and subsequent oligospermia.  The 
aim of this study was to determine if a modified micropipette pressure transducing 
system (MPTS) could determine the adhesion force between Sertoli cells and germ 
cells.  Using the MPTS this study examined, for the first time, the strength of the junction 
between Sertoli cells and spermatids and between Sertoli cells and spermatocytes.  The 
mean force needed to detach spermatocytes from Sertoli cells was 5.25x10-7 pN, pre-
step-8 spermatids from Sertoli cells was 4.73x10-7 pN, step-8 spermatids from Sertoli 
cells was 8.82x10-7 pN, and spermatids + EDTA was 2.16x10-7 pN.  These data confirm 
the hypothesis that step-8 spermatids are more firmly attached to Sertoli cells than are 
spermatocytes and pre-step-8 spermatids and that calcium chelation reduces binding 
strength between Sertoli cells and spermatids.  The MPTS is a useful tool in studying the 
various molecular models of the Sertoli-germ cell junctional strength and the role of 
reproductive hormones and enzymes in coupling and uncoupling of germ cells from 
Sertoli cells.
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INTRODUCTION 
 
The complicated process of spermatogenesis occurs throughout the reproductive 
life of the male.  It is a remarkable process in which spermatogonia undergo mitosis to 
become spermatocytes, which then undergo meiosis to become round spermatids, 
which then enter the process of spermiogenesis to differentiate into elongated 
spermatids (sperm) [1].  At any given point in time several generations of germ cells are 
present in the seminiferous epithelium but in different stages of maturation [2].  During 
spermatogenesis, germ cells form different types of junctions with Sertoli cells, including 
the specialized ectoplasmic specialization between Sertoli cells and spermatids [3]. 
Several types of intercellular junctions, including occluding junctions, adherens 
junctions, and gap communicating junctions, are believed to play crucial roles in 
spermatogenesis.  The actin based cell-cell adherens junction between the Sertoli cell 
and the germ cell in the mammalian testis are important not only in mechanical adhesion 
of the cells, but in the morphogenesis and differentiation of the germ cells [4].  Turnover 
of these calcium dependent junctions occurs during the process of germ cell migration 
from the basal to the adluminal epithelial compartment [5]. 
The Sertoli ectoplasmic specialization, a cytoskeletal structure of the Sertoli cell, 
is associated with Sertoli-spermatid binding at the adherens junction [6,7].  Abnormal or 
absent Sertoli ectoplasmic specializations have been associated with a reduction of 
mature sperm in semen [8-11] and conditions associated with oligospermia [12].  
ectoplasmic specializations are found basally in the Sertoli cell near Sertoli-Sertoli tight 
junctions and apically between Sertoli cells and spermatids.  They consist of hexagonally 
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packed bundles of actin filaments situated between the plasma membrane and a cistern 
of endoplasmic reticulum [4].  The ectoplasmic specialization is an important cell-cell 
adhesion mechanism in the seminiferous epithelium to ensure the retention of 
spermatids as they mature into spermatozoa.  ectoplasmic specializations are first seen 
in the rat at Stage VIII of rat spermatogenesis, when the step-8 spermatid appears.  It is 
thought the ectoplasmic specialization forms in the Sertoli cell to strongly anchor the 
step-8 spermatid to the seminiferous epithelium; however, this has yet to be actually 
measured.  The ectoplasmic specialization is present at the adherens junction until 
appropriate release of the step-19 spermatid and inappropriate release of earlier stage 
spermatids (i.e., spermatid sloughing) is related to abnormal ectoplasmic specialization 
structure and oligospermia [10,11].   
A number of health-related conditions are associated with reduced fertility 
potential and oligospermia in men, including varicocele, hyperprolactinemia, diabetes, 
and idiopathic oligospermia [12].  These conditions all are associated with reduced 
sperm in the semen, i.e., oligospermia, and ultrastructural pathology unique to the 
junctional apparatus of the seminiferous epithelium [12].  Cap stage spermatids in the 
human (step-8 spermatids in the rat) are presumed to be tightly anchored to the 
seminiferous epithelium at a Sertoli cell adherens junction, which includes the unique 
Sertoli ectoplasmic specialization [6,7].  In both in vitro and in vivo observations of 
experimental animal models, disruption of this junction results in spermatid sloughing 
and subsequent oligospermia [8-11]. 
This project was designed to measure the strength of junctions between germ 
cells and Sertoli cells and to determine if the presence of the unique ectoplasmic 
specialization between Sertoli cells and step-8 spermatids actually results in an increase 
in the binding strength between these two cell types.  To do this, we have modified a 
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micropipette pressure transducing system for the purpose of testing junctional strengths 
between cells in a Sertoli-germ cell coculture model optimized for cell-cell binding [13].  It 
is hypothesized that the junctions between step-8 spermatids and Sertoli cells are 
stronger than those between pre-step-8 spermatids and Sertoli cells and between 
spermatocytes and Sertoli cells. 
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MATERIALS AND METHODS 
 
Sertoli and germ cells were isolated from Sprague-Dawley rats, as previously 
described [14].  Sixteen- to seventeen-day-old rats were used for Sertoli cell isolation, 
and adult rats were used for germ cell isolation. 
 Sertoli cell isolation, culture, and pre-treatment 
Briefly, testes were excised from prepubertal male rats, and the parenchyma was 
digested using routine sequential enzymatic treatments with trypsin (0.25%, Sigma) and 
collagenase (0.20%, BD).  Isolated cells were plated to confluence on 13 mm round 
plastic coverslips coated with undiluted Matrigel® in 24 well cell culture dishes.  Cultures 
were incubated in DMEM:F12 medium (supplemented with 0.01 mol/L retinol and 1000 
µl/100 ml ITS) at 39°C in a humidified incubator with 5% CO2-95% air for 48 hrs to 
expedite the removal of contaminating germ cells.  After the 48 hr pre-incubation, the 
cultures were exposed to a 20 mM Tris-HCl buffer for 2.5 min to hypotonically lyse 
remaining germ cells, then incubated in supplemented DMEM:F12 at 33°C in a 
humidified incubator with 5% CO2-95% air for 24 hrs.  After the 24 hr incubation, the 
media was replaced with supplemented DMEM:F12 containing 0.06 µg/ml FSH (NIDDK-
oFSH-20, AFP7028D, 175xNIH-FSH-S1) and 100 nM testosterone (Sigma).  These pre-
treated Sertoli cell cultures were used in all coculture experiments. 
Spermatocyte and round spermatid isolation and unit gravity velocity 
sedimentation  
Spermatocytes and pre-step 9 spermatids (round spermatids) were isolated from 
an adult male rat testis.  Briefly, the decapsulated adult testis was digested with 0.10% 
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collagenase (Gibco; 37°C, 80 oscillations/min, 30 min) to separate seminiferous tubules 
from the testicular interstitial tissue.  The washed seminiferous tubules then were 
digested with 0.25% trypsin (Sigma; 37°C, 90 oscillations/min, 15 min) to separate the 
peritubular cells from the seminiferous epithelium and to expedite the release of germ 
cells from the seminiferous epithelium.  A 0.20% trypsin inhibitor solution (Sigma) was 
added to terminate the trypsin reaction.  The resulting cell suspension (mixed germ cells 
and Sertoli cells) was resuspended in 25 ml McCoy’s media + 0.5% BSA. 
Using sterile technique, the gradient chambers on a STA-PUT velocity 
sedimentation cell separator were filled with the appropriate McCoy's + BSA medium 
(2% and 4% BSA), and a linear gradient (2-4%) was built under the cell suspension, at 
the loading rate initially at 10 ml/min.  After 20 minutes, the rate was increased to 40 
ml/min.  Eighty minutes prior to the end of the collection time (4 h), media with germ cell 
fractions were collected using a Fractomat automatic fraction collector (10 ml/vial at 160 
drops/min).  Spermatocytes and round spermatids (pre-step 9) were identified by phase 
contrast microscopy and pooled, washed, and resuspended in McCoy's media.  The 
number of cells in the spermatocyte and spermatid fractions were counted by 
hemocytometric analysis and assayed for viability by trypan blue exclusion. 
Sertoli-germ cell coculture 
Approximately 400,000 isolated germ cells (spermatocytes and round 
spermatids) were added directly to the pre-treated Sertoli cell enriched monocultures.  
The Sertoli-germ cell cocultures were incubated with 0.06 µg/ml FSH + 100 nM 
testosterone in a humidified chamber at 33°C with 5% CO2-95% air for 36 hrs. 
Measurement of junctional strength using a micropipette pressure transducing 
system (MPTS)  
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The Sertoli-germ cell cocultures were imaged on an inverted interference 
contrast microscope (Axiovert 100, Zeiss) with a 20x objective.  The microscope was 
fitted with the MPTS, which consisted of a 3-D water robot micromanipulator (Narishige 
Scientific Instruments Lab), a micropipette holder, a glass micropipette, a water reservoir 
system to control the micropipette pressure, and a video system to record experiments 
(Figure 2.1).  
Figure 2.1. A schematic drawing of the micropipette pressure transducing system (MPTS). 
The micropipette 
Micropipettes were created from 1mm-outer diameter, 0.5mm-inner diameter 
glass capillary tubes (A-M Systems, Inc.).  The capillary tube was mounted onto a 
pipette puller (Model PB-7, Narishige Scientific Instruments), heated, and pulled into a 
pipette with a tip of a few microns.  To ensure a flat tip, this pipette was then mounted 
onto a microforge (Model MF 83, Narishige Scientific Instruments).  The microforge 
consists of a horizontal microscope, a micromanipulator, and a glass bead on a platinum 
  70 
wire.  Upon heating of the wire, the glass bead melted and the tip of the micropipette 
was inserted into the melted glass.  The bead/micropipette was allowed to cool.  The 
micropipette was then pulled up, and the tip was broken by quick fracture, leaving a flat 
tip.  The tip was filled with a saline solution to avoid plugging.  In order to prevent rupture 
of the cells on the glass surface, the micropipette was coated with plasma proteins.  The 
diameters of the pipettes used were 13.32 µm for spermatids (diameter 10 µm) and 
16.65 µm for spermatocytes (diameter 15 µm). 
The water reservoir system 
The pressure at the tip of the micropipette was controlled by a system consisting 
of two water reservoirs and a pressure transducer (Model DP15-30, Validyne) connected 
between the two reservoirs.  One reservoir was a reference reservoir and the other one 
was an adjustable reservoir.  The reference reservoir was adjusted so that no pressure 
would be applied at the micropipette.  This was achieved by connecting the reference 
reservoir directly to the micropipette and positioning it at the same level as the 
micropipette.  As a result, there were no movements from particles or cells in front of the 
micropipette.  The adjustable reservoir was then positioned to create the desired 
pressure, as read by the pressure transducer.  A valve switch was used to connect the 
micropipette either to the reference reservoir or the adjustable reservoir.  The pressure 
transducer output signal was decoded via a carrier demodulator (Model CD 280-2, 
Validyne).  The pressure range of the transducer was 80,000 dyn/cm2 with an accuracy 
of 400 dyn/cm2. 
Cell measurements 
Cover slips containing Sertoli-germ cell cocultures were carefully removed from 
the wells and placed in an engineered cover slip holder for use with the MPTS-fitted 
inverted microscope.  The detachment of germ cells from Sertoli cells was measured 
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and analyzed.  In some experiments, 2mM or 4mM EDTA was added to the cultures 
immediately before the measurements, as controls.  To detach germ cells from Sertoli 
cells, the micropipette was brought near the individual spermatocyte or the individual 
spermatid at 200x magnification.  The pressure required to detach the germ cell from the 
underlying Sertoli cell monolayer was then recorded.  Each detachment event (a 
maximum of 4) consisted of a 5 second suction pressure interval.  If the germ cell did not 
dissociate, it was abandoned, and the last pressure reading was recorded.  The 
recorded pressure (in cm-H2O) was used to calculate force via the equation F = ?P • 
pR2p, where F (pN) is the force on a static cell, ?P is the suction pressure (N/µm2), and 
pR2p is the cross sectional area of the pipette (µm2).  To convert the pressure reading 
received in cm-H2O to N/µm2, for use in the above equation, the conversion factors 1 
cm-H2O = 98.06 Pa and 1 Pa = N/m2 were used, since the international unit of force is 
Newtons (1 N = 1 kg•m/s2), and the international unit of pressure is Pascal (Pa).  
Statistics 
To determine statistical significance of the mean force (set at the 0.05 level), a 
one-way ANOVA was performed, followed by Tukey HSD. 
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RESULTS 
 
The mean force required to detach spermatocytes, pre-step-8 spermatids, and 
step-8 spermatids from Sertoli cells in the optimized Sertoli-germ cell in vitro binding 
model was determined following multiple measurements acquired from the modified 
MPTS.  The mean force necessary to detach spermatocytes from Sertoli cells was 
5.25x10-7 pN (SE= 3.43x10-8, n=38), pre-step-8 spermatids from Sertoli cells (i.e., 
Sertoli-spermatid junctions with no ES) was 4.73x10-7 pN (SE= 2.17x10-8, n=38), step-8 
spermatids from Sertoli cells (i.e., Sertoli-spermatid junctions with ES) was 8.82x10-7 pN 
(SE= 3.37x10-8, n=33), and spermatids + EDTA was 2.16x10-7 pN (SD= 3.12x10-8, n=6).  
These results are presented in Figure 2.2.   
A one-way ANOVA determined a significant difference between the mean force 
of spermatocytes and the mean force of step-8 spermatids, between the mean force of 
pre-step-8 spermatids and the mean force of step-8 spermatids, and between the mean 
force of spermatids versus spermatids + EDTA, where p<0.05.  There was no significant 
difference between the mean force of spermatocytes and the mean force of pre-step-8 
spermatids.   
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Figure 2.2. Bar graph and line chart displaying the mean force (pN) required to detach spermatocytes, pre-
step-8 spermatids, and step-8 spermatids from Sertoli cells in vitro with FSH+T. * indicates a significant 
difference, as determined by one-way ANOVA. 
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DISCUSSION 
 
It is theorized that spermatids associated with ectoplasmic specializations adhere 
to Sertoli cells more strongly than all other germ cells and that this is essential for 
anchoring spermatids in the seminiferous epithelium during the final stages of 
spermiogenesis.  Additionally, complete spermiogenesis is not observed in the absence 
of these unique Sertoli-spermatid junctions, which when disrupted lead to spermatid 
sloughing and oligospermia [8-10].  However, the actual junctional strength between 
Sertoli cells and spermatids has never been measured to verify this unsubstantiated 
dogma central to the successful completion of spermatogenesis. 
We have, for the first time, determined the actual strength of junctions between 
germ cells and Sertoli cells in vitro.  The data presented confirm the hypothesis that 
step-8 spermatids are more firmly attached to Sertoli cells than are spermatocytes and 
pre-step-8 spermatids.   
Of the cells tested, the ectoplasmic specialization is only present between Sertoli 
cells and step-8 – step-19 spermatids and is conspicuously absent between Sertoli cells 
and spermatocytes and pre-step-8 spermatids [4]. This suggests that the structural 
nature of the ectoplasmic specialization contributes to the actual junctional strength 
between these two cell types, ensuring that elongating spermatids (post-step-8 
spermatids) are securely anchored to the seminiferous epithelium during the final stages 
of spermiogenesis.  This also supports the hypothesis that when the ectoplasmic 
specialization does not form properly between the Sertoli cell and the periluminal step-8 
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spermatid, or is otherwise abnormal, the junction strength is significantly lessened, 
thereby leading to spermatid sloughing and oligospermia [12]. 
Several molecular models of the structure and regulation of the ectoplasmic 
specialization at the Sertoli cell-spermatid junction have been proposed.  One such 
model includes the controversial and most studied cadherin-catenin complex.  In this 
model, it is proposed that the presence and regulation of the multi-protein cadherin-
catenin complex at the ectoplasmic specialization controls the coupling and uncoupling 
of spermatids to Sertoli cells [15-17].  Disruption of this protein complex via 
phosphorylation of p120ctn [18], tyrosine phosphorylation of ß- and/or g-catenin [18], 
and/or the addition of an anti-N-cadherin antibody [17,19] results in the loss of germ cells 
from the seminiferous epithelium.  This step-8 sloughing, as described by O’Donnell et al 
[10], is also related to testosterone reduction and possibly, therefore, N-cadherin 
expression [17,20,21].  In vitro, testosterone and DHT with a fixed concentration of FSH 
causes a dose-related increase in N-cadherin levels [19].  Increasing doses of FSH in 
the presence of a fixed concentration of testosterone also creates a dose-related 
increase in N-cadherin protein levels [19].  In the models studied, the ectoplasmic 
specialization is still present, therefore indicating that testosterone has an effect on the 
cell adhesion molecules at this junction and not the ectoplasmic specialization structure 
itself [11, 20,21].  The effects of reproductive hormones on cell adhesion and coupling 
and uncoupling dynamics between Sertoli cells and germ cells, as defined above, can be 
tested utilizing the MPTS. 
Other proposed molecular models of the Sertoli-spermatid ectoplasmic 
specialization consist of the nectin-afadin-ponsin complex and the integrin complex.  
Nectins are found in both Sertoli cells (nectin-2) and spermatids (nectin-3), with the 
strongest expression at stages IX-IV and decreasing at stage VIII [22,23].  1-Afadin, 
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found in the testis, connects to the actin cytoskeleton [24], and studies using afadin-/- 
mice have shown that afadin is essential in proper structural organization of tight 
junctions and cadherin-based AJs [25].  Ponsin, of which mRNA is found in the testis 
[26], binds to afadin and allows it to colocalize with nectin to the cadherin-based 
adherens junction [24].  However, no biochemical or functional studies on the nectin-
afadin-ponsin complex have been conducted.   
The most studied integrin receptor in the testis is a6ß1, which is found in the 
Sertoli cell membrane [for review 27].  The binding partner of a6ß1 is not yet known, but 
recent studies have indicated that the laminin g3 chain is a putative binding partner [28-
30].  The expression of ß1-integrin has been shown to be affected by hormones.  
Testosterone, in the presence of FSH, increases ß1-integrin levels in a dose-dependent 
manner [31], as do increasing doses of FSH in the presence of testosterone.  Integrins 
are important in cell adhesion not only structurally, but also in that they transmit signals 
to trigger events that activate signal transducers, such as Rho GTPase [32], FAK 
[29,33], Src [16], Csk [16], and ILK [29], to affect Sertoli-germ cell AJ dynamics [5].  
Again, the effects of reproductive hormones on the integrin-based model of the Sertoli-
germ cell junction and its role in coupling and uncoupling of germ cells from Sertoli cells 
can be tested with the MPTS. 
Results from this study show that the junctional strength between Sertoli cells 
and germ cells can be measured in vitro, support long held speculations regarding 
Sertoli-spermatid junctional interactions, and provide a means to actually test proposed 
mechanisms of junction dynamics between cells of the seminiferous epithelium. 
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CHAPTER 3 
 
The Sertoli-spermatid junctional complex adhesion strength is affected in vitro by 
Adjudin. 
In Press: Journal of Andrology
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ABSTRACT 
 
The actin based cell-cell adherens junction between the Sertoli cell and the germ 
cell in the mammalian testis is important not only in mechanical adhesion of the cells, but 
in the morphogenesis and differentiation of the germ cells.  The Sertoli ectoplasmic 
specialization, a specialized type of adherens junction, is associated with Sertoli-
spermatid binding and is important in cell-cell adhesion in the seminiferous epithelium.  
Abnormal or absent Sertoli ectoplasmic specializations have been associated with step-
8 spermatid sloughing and oligospermia in conditions associated with reduced fertility 
potential.  The reproductive hormones follicle stimulating hormone (FSH) and 
testosterone also have been shown to play a role in the regulation of binding of 
spermatids at the Sertoli-spermatid junctional complex.  Adjudin [1-(2,4-dichlorobenzyl)-
1H-indazole-3-carbohydrazide] is a potential male contraceptive and is thought to exhibit 
its contraceptive effects by interrupting the Sertoli-spermatid junctional complex.  It has 
been shown that this compound induces reversible germ cell loss from the seminiferous 
epithelium, particularly elongating/elongate/round spermatids and spermatocytes.  The 
aim of this study was to determine if Adjudin disrupts the junctional strength between the 
Sertoli cell and step-8 spermatid in vitro.  Using a micropipette pressure transducing 
system (MPTS) to measure the force needed to detach step-8 spermatids from Sertoli 
cells, this study examined the strength of the Sertoli-spermatid junctional complex in 
Sertoli-spermatid cocultures in the presence of Adjudin (1 ng/ml, 50 ng/ml, 125 ng/ml, or 
500 ng/ml in EtOH) and hormones [FSH (0.1 µg/ml, NIDDK-oFSH-20, AFP7028D, 
175xNIH-FSH-S1), testosterone (100 nM)] to optimize in vitro binding.  The average 
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forces required to detach the spermatids from the underlying Sertoli cells in the presence 
of 1 ng/ml, 50 ng/ml, 125 ng/ml and 500 ng/ml Adjudin were 18.2x10-10 pN, 14.3x10-10 
pN, 7.74x10-10 pN and 6.51x10-10 pN, respectively.  The average force required to detach 
step-8 spermatids in the presence of vehicle only (control) was 19.0x10-10 pN.  A 
significant difference for Adjudin concentrations at or above 125 ng/ml was determined 
by one-way ANOVA (p<0.05).  These data confirm that Adjudin is effective in reducing 
the strength of the Sertoli-spermatid junctional complex, identifying Adjudin as a 
potential contraceptive agent in the male by inducing spermatid sloughing and therefore 
oligospermia. 
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INTRODUCTION 
 
Spermatogenesis, the process in which germ cells undergo mitosis and meiosis 
to become elongated spermatids (sperm) [1], occurs throughout the reproductive life of 
the male.  Present in the seminiferous epithelium at any given point in time are several 
generations of germ cells in different stages of maturation [2].  Various types of junctions 
between these developing germ cells and Sertoli cells exist throughout 
spermatogenesis, including the highly specialized ectoplasmic specialization found 
between Sertoli cells and germ cells [3]. 
The ectoplasmic specialization is an apical cytoskeletal structure of the Sertoli 
cell associated with Sertoli-spermatid binding at the adherens junction [4,5].  This 
structure is important in cell-cell adhesion in the seminiferous epithelium, ensuring the 
retention of spermatids as they mature into spermatozoa.  It is believed that the 
ectoplasmic specialization forms to strongly anchor the step-8 spermatid to the 
seminiferous epithelium.  In the rat, ectoplasmic specializations are first seen at Stage 
VIII of spermatogenesis, the time when the step-8 spermatid appears, and are present at 
the adherens junction until appropriate release of the step-19 spermatid.  Inappropriate 
release of spermatids (i.e., spermatid sloughing) is related to abnormal ectoplasmic 
specialization structure and oligospermia [6,7].  A reduction of mature sperm in semen 
[6-9] and conditions associated with oligospermia are associated with structurally 
abnormal or absent Sertoli ectoplasmic specializations [10].   
A number of health-related conditions are associated with reduced fertility 
potential and oligospermia in men, including varicocele [11], hyperprolactinemia [12], 
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diabetes [13], and idiopathic oligospermia [10].  These conditions all are associated with 
reduced sperm in the semen, i.e., oligospermia, and ultrastructural pathology unique to 
the junctional apparatus of the seminiferous epithelium [10].  Cap stage spermatids in 
the human (step-8 spermatids in the rat) are presumed to be tightly anchored to the 
seminiferous epithelium at a Sertoli cell adherens junction, which includes the unique 
Sertoli ectoplasmic specialization [4,5].  In both in vitro and in vivo observations of 
experimental animal models, disruption of this junction results in spermatid sloughing 
and subsequent oligospermia [6,7,8,9]. 
Adjudin, formerly known as AF-2364 (1-(2,4-dichlorobenzyl)-1H-indazole-3-
carbohydrazide), depletes seminiferous tubules of germ cells [14,15].  By day 14 of 
administration of Adjudin, adult seminiferous tubules are found nearly devoid of 
elongated and round spermatids and spermatocyte numbers have been reduced, with 
no significant effect on reproductive hormone levels [15].  Although speculated, it is not 
yet been determined whether Adjudin works at the level of the adherens junction or the 
ectoplasmic specialization. 
This project was designed to measure the strength of junctions between step-8 
spermatids and Sertoli cells in the presence of various concentrations of Adjudin.  To do 
this, a micropipette pressure transducing system was used to measure the force needed 
to detach step-8 spermatids from Sertoli cells [16] in the presence of Adjudin (0 ng/ml, 1 
ng/ml, 50 ng/ml, 125 ng/ml, or 500 ng/ml in EtOH) [17] and reproductive hormones 
(follicle stimulating hormone and testosterone).  It is hypothesized that Adjudin at higher 
concentrations will disrupt the Sertoli-spermatid junctional complex and cause reduced 
binding strength between the Sertoli cell and step-8 spermatid. 
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MATERIALS AND METHODS 
 
Sertoli and germ cells were isolated from Sprague-Dawley rats, as previously 
described [18].  Sixteen- to seventeen-day-old rats were used for Sertoli cell isolation, 
and adult rats were used for germ cell isolation. 
Sertoli cell isolation, culture, and pre-treatment 
Briefly, testes were excised from prepubertal male rats, and the parenchyma was 
digested using routine sequential enzymatic treatments with trypsin (0.25%, Sigma) and 
collagenase (0.20%, BD).  Isolated cells were plated to near confluence on 13 mm round 
glass coverslips coated with 1:3 Matrigel (BD) in culture medium in 24-well cell culture 
dishes.  Cultures were incubated in DMEM:F12 medium [supplemented with 0.01 mol/L 
retinol (Sigma), 1000 µl/100 ml ITS (BD), 500 µl/500 ml gentamicin (Sigma) and 5 
ml/500 ml antibiotic/antimycotic (Cellgro)] at 39°C in a humidified incubator with 5% CO2-
95% air for 48 hrs to expedite the removal of contaminating germ cells.  After the 48 hr 
pre-incubation, the cultures were exposed to a 20 mM Tris-HCl buffer for 2.5 min to 
hypotonically lyse any remaining germ cells, then incubated in supplemented 
DMEM:F12 at 33°C in a humidified incubator with 5% CO2-95% air for 24 hrs.  After the 
24 hr incubation, the media was replaced with supplemented DMEM:F12 containing 0.06 
µg/ml follicle stimulating hormone (FSH; NIDDK-oFSH-20, AFP7028D, 175xNIH-FSH-
S1) and 100 nM testosterone (T; Sigma) to optimize in vitro Sertoli-spermatid binding.  
These pre-treated Sertoli cell cultures were used in the coculture experiments. 
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Round spermatid isolation and unit gravity velocity sedimentation 
Pre-step 9 spermatids (round spermatids) were isolated from an adult male rat 
testis.  Briefly, the decapsulated adult testis was digested with 0.10% collagenase 
(Gibco; 37°C, 80 oscillations/min, 30 min) to separate seminiferous tubules from the 
testicular interstitial tissue.  The washed seminiferous tubules then were digested with 
0.25% trypsin (Sigma; 37°C, 90 oscillations/min, 15 min) to separate the peritubular cells 
from the seminiferous epithelium and to expedite the release of germ cells from the 
seminiferous epithelium.  A 0.20% trypsin inhibitor solution (Sigma) was added to 
terminate the trypsin reaction.  The resulting cell suspension (mixed germ cells and 
Sertoli cells) was resuspended in 25 ml McCoy’s media + 0.5% BSA. 
Using sterile technique, the gradient chambers on a STA-PUT velocity 
sedimentation cell separator were filled with the appropriate McCoy's + BSA medium 
(2% and 4% BSA), and a linear gradient (2-4%) was built under the cell suspension, at 
the loading rate initially at 10 ml/min.  After 20 minutes, the rate was increased to 40 
ml/min.  Eighty minutes prior to the end of the collection time (4 h), media with germ cell 
fractions were collected using a Fractomat automatic fraction collector (10 ml/vial at 160 
drops/min).  Round spermatids (pre-step 9) were identified by phase contrast 
microscopy and pooled, washed, and resuspended in McCoy's media.  The number of 
cells in the spermatocyte and spermatid fractions were counted by hemocytometric 
analysis and assayed for viability by trypan blue exclusion. 
Sertoli-germ cell coculture 
Approximately 400,000 isolated germ cells (round spermatid-enriched) were 
added directly to the pre-treated Sertoli cell enriched monocultures.  The Sertoli-germ 
cell cocultures were incubated in a humidified chamber at 33°C with 5% CO2-95% air for 
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36 hrs with 0.06 µg/ml FSH + 100 nM T to optimize Sertoli-spermatid binding as 
previously described [19, 20]. 
Addition of Adjudin to the coculture 
After 30 hrs of incubation, Vehicle 1 (2.5 µl EtOH) was added to one column of 
the 24-well plate and incubated for 1 hr at 33°C.  After the 1 hour incubation time, the 
next column received 1 ng/ml Adjudin in 2.5 µl EtOH and incubated for 1 hr at 33°C.  
This continued with the remaining concentrations of Adjudin (50 ng/ml, 125 ng/ml and 
500 ng/ml) [17] and ended with Vehicle 2 (same as Vehicle 1) to ensure that time was 
not the factor affecting the junction. 
Measurement of junctional strength using a micropipette pressure transducing 
system (MPTS) 
The Sertoli-germ cell cocultures were imaged on an inverted interference 
contrast microscope (Axiovert 100, Zeiss) with a 20x objective.  The microscope was 
fitted with the MPTS, as previously described [16].  After the 1 hr incubation with the 
treatment, the cover slips were washed 5x by gentle pipetting with supplemented 
DMEM:F12 + FSH and T (without Adjudin or EtOH).  Cover slips containing the Sertoli-
germ cell cocultures were carefully removed from the well.  A step-8 spermatid were 
identified as a 10 µm round cell containing an eccentric nucleus, as previously described 
[19, 21].  The detachment of individual step-8 spermatids from Sertoli cells and 
subsequent force measurement and analysis was performed as previously described 
[16].  Briefly, pressure at the tip of a 10 µm-diameter micropipette was controlled by a 
system consisting of two water reservoirs and a pressure transducer connected between 
the two reservoirs.  To detach spermatids from Sertoli cells, the glass micropipette tip 
was brought into close proximity to the unbound cell surface of the spermatid, and the 
hydrostatic pressure required to detach it from the underlying Sertoli cell monolayer was 
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recorded on the transducer.  The recorded pressure (in cm-H2O) was used to calculate 
force via the equation F = ?P • pR2p, where F (pN) is the force on a static cell, ?P is the 
suction pressure (N/µm2), and pR2p is the cross sectional area of the pipette (µm2).  To 
convert the pressure reading received in cm-H2O to N/µm2, for use in the above 
equation, the conversion factors 1 cm-H2O = 98.06 Pa and 1 Pa = N/m2 were used, 
since the international unit of force is Newtons (1 N = 1 kg•m/s2), and the international 
unit of pressure is Pascal (Pa). Each detachment event (a maximum of 4) consisted of a 
5 second suction pressure interval.  If the germ cell did not dissociate, the detachment 
effort was abandoned, and the last pressure reading was recorded.   
Viability/cytotoxicity assays 
 Sertoli cell cultures were prepared from 20-day-old rat testes by sequential 
enzymatic treatments as described [18], and cells were plated at high-density (0.5 x 106 
cells/cm2) on Matrigel™ (diluted 1:7 with Ham’s F-12 Nutrient Mixture and Dulbecco’s 
Modified Eagle’s Medium [F-12/DMEM], 1:1; Sigma)-coated Nunclon 24-well dishes in F-
12/DMEM supplemented with 10 µg/ml bovine insulin, 5 µg/ml human transferrin, 10 
µg/ml bacitracin,  2.5 ng/ml EGF, 0.06 µg/ml FSH and 100 nM T.  To obtain Sertoli cells 
with a purity greater than 98%, cultures were hypotonically treated.  Media were 
replaced every 24 hr thereafter, and Sertoli cells were incubated for an additional 3 days.  
This was followed by the isolation of germ cells from 90-day-old rat testes as previously 
described [22,23].  In this experiment, germ cell preparations were exposed to 
successive glass wool filtration steps, and thus, consisted of spermatogonia, 
spermatocytes, round and elongating spermatids when examined microscopically.  
Germ cells were added directly to Sertoli cell cultures at a Sertoli:germ cell ratio of 1:3 
and cocultured for 36 hr [24].  Thereafter, cocultures were rinsed twice with media to 
remove unbound germ cells and increasing concentrations of Adjudin (1, 50, 125 and 
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500 ng/ml, and 1 µg/ml) were added.  Sertoli-germ cell cocultures were incubated for 0, 
1, 3, 6 and 12 hr.  These cocultures were then used for viability/cytotoxicity assays.  
Because viable cells are characterized by the presence of intracellular esterase activity, 
this assay measured the ability of cells to enzymatically convert non-fluorescent, cell-
permeable calcein AM to fluorescent calcein.  Briefly, media was removed from Sertoli-
germ cell cocultures and cells gently rinsed with media.  Calcein AM (~2-5 µM, prepared 
in media or PBS, pH 7.4 prior to immediate use to prevent hydrolysis; Invitrogen) was 
added to Sertoli-germ cell cocultures and incubated briefly at 37 ºC or room 
temperature.  Fluorescence was quantified at 10-15 min intervals for up to 60 min at 485 
nmEX and 535 nmEM using a Tecan GENios fluorescence plate reader.  Controls 
consisted of Sertoli-germ cell cocultures cultured in the absence of Adjudin and in the 
presence of vehicle (ethanol:DMSO, 1:1 dilution).  Non-viable Sertoli-germ cell 
cocultures, which lacked the ability to enzymatically convert calcein AM to calcein, were 
prepared by treating cells with 75% ethanol (30 min) or 0.5% saponin (10 min).           
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RESULTS 
 
The mean force required to detach step-8 spermatids from Sertoli cells in the 
optimized Sertoli-germ cell in vitro binding model in the presence of various 
concentrations of Adjudin was determined following multiple measurements acquired 
from the modified MPTS.  The mean force necessary to detach step-8 spermatids from 
Sertoli cells (i.e., Sertoli-spermatid junctions with ectoplasmic specializations) in the 
presence of Vehicle 1 (at the start of the measurement process) and Vehicle 2 (at the 
end of the measurement process) was 18.03x10-10 pN (SE=1.263x10-6, n=16) and 
19.92x10-10 pN (SE=1.149x10-6, n=16).  The average for the two Vehicle groups was 
19.0x10-10 pN.  In the presence of 1 ng/ml, 50 ng/ml, 125 ng/ml and 500 ng/ml Adjudin, 
the mean forces required to detach step-8 spermatids from the underlying Sertoli cell 
monoculture were 18.2x10-10 pN (SE=1.383x10-6, n=16), 14.3x10-10 pN (SE=1.412x10-6, 
n=16), 7.74x10-10 pN (SE=1.122x10-6, n=16) and 6.51x10-10 pN (SE=1.750x10-6, n=10), 
respectively (Figure 3.1).  A one-way ANOVA determined a significant difference for 
Adjudin concentrations at or above 125 ng/ml, where p<0.05.   
 Viability/cytotoxicity assays demonstrated that the viability of Sertoli-germ cell 
cocultures was not affected when these cells were incubated with increasing 
concentrations of Adjudin for up to 12 hr (Figure 3.2).  Time points beyond 12 hr were 
not examined because higher doses of Adjudin (500 ng/ml and 1 µg/ml) perturb Sertoli-
germ cell adhesion, resulting in a decrease in cell number in these wells.           
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Figure 3.1.  Bar graph displaying the effect of Adjudin on the mean force (in piconewtons, pN) 
required to detach step-8 spermatids from Sertoli cells in the optimized Sertoli-spermatid 
coculture binding model. * indicates a significant difference, as determined by one-way ANOVA. 
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Figure 3.2.  Bar graph illustrating that increasing concentrations of Adjudin (0, 1, 50, 125 and 500 ng/ml, and 
1 µg/ml) at 12 hr post-treatment had no effect on the viability of Sertoli-germ cell cocultures when compared 
to controls (0 ng/ml Adjudin and vehicle). 
 
 
 
 95 
 
 
 
DISCUSSION 
 
It is hypothesized that Adjudin works at the level of the adherens junction and 
possibly the ectoplasmic specialization in the seminiferous tubules, since depletion of 
round and elongated spermatids is seen in rats after administration of this potential male 
contraceptive [14,15,25].  However, cell adhesion was not compromised in other organs 
such as the brain, liver and kidney when this drug was administered by gavage, inter-
peritoneal or intramuscular injection [25] nor was the hypothalamus-pituitary-testicular 
axis affected at doses that were effective to induce male infertility [14].  Additionally, 
administration of Adjudin (50 mg/kg b.w., 3 doses administered every 2 days) to pups 
(e.g., 5-25 days of age) did not effect the integrity of Sertoli-germ cell adherens junctions 
[26], suggesting that the apical ectoplasmic specialization is an initial target.  Upon 
metabolic removal of Adjudin from virtually all organs by 48 hr, spermatogenesis began 
to resume progressively, and by day ~100 the testes of treated animals were 
indistinguishable from controls [14].  However, it was not known whether this compound 
actually affects the strength of the Sertoli-spermatid junctional complex.   
We have, for the first time, determined that the strength necessary to detach 
step-8 spermatids from a Sertoli cell monolayer is reduced by specific doses of Adjudin 
in vitro, indicating a functional alteration of the Sertoli-spermatid junctional complex.  The 
data presented confirm the hypothesis that this compound, at higher concentrations, 
disrupts the Sertoli-spermatid junctional complex, causing weaker binding between the 
Sertoli cell and step-8 spermatid.  Only the Sertoli-spermatid junctional complex between 
step-8 spermatids and Sertoli cells, which contains the ectoplasmic specialization, was 
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tested.  It is not known whether Adjudin affects the strength of desmosome-like junctions 
that are present, for example, between Sertoli and pachytene spermatocytes.  Recent 
studies have suggested that Adjudin affects the ectoplasmic specialization by activating 
RhoB within hours of administration.  This in turn activated ROCK, LIMK1 and cofilin, 
which perturbed actin cytoskeleton dynamics and resulted in germ cell detachment [27].  
Moreover, ß1 integrin, which is predominantly located at the apical ectoplasmic 
specialization, was also shown to be up-regulated following Adjudin treatment, further 
activating the FAK/PI 3-kinase/p130Cas/MAP kinase [17] pathway.   Though the exact 
protein complex acting as the receptor for Adjudin has not yet been defined, it is thought 
that through these signaling pathways, changes in the polymerization and 
depolymerization of actin at the ectoplasmic specialization lead to a depletion of germ 
cells from the seminiferous epithelium, in particular round and elongating spermatids 
[25].  It should be noted that Adjudin is a chemical entity that shares structural 
similarities with lonidamine [1-(2,4)-dichlorobenzyl-1H-indazole-carboxylic acid], which is 
known to severely damage stress fibers (e.g., actin filaments) in Sertoli cells [28,29].  
Likewise, preliminary studies have shown that Adjudin can induce extensive remodeling 
of the actin cytoskeleton in these cells (Mruk and Cheng, unpublished observations).  
What remains to be determined, however, is why Sertoli cell actin at the apical 
ectoplasmic specialization is sensitive to Adjudin’s effects when this protein is a 
constituent of virtually all cell types.  Certainly, other upstream regulators of RhoB 
activity, as well as additional signaling cascades, are likely to be involved, and their 
identification will help in determining why the apical ectoplasmic specialization is a 
primary target for Adjudin-mediated restructuring in the testis.    
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Results from this study show that the junctional strength between Sertoli cells 
and step-8 spermatids is reduced by Adjudin in vitro, supporting the potential use of this 
chemical as a male contraceptive. 
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CHAPTER 4 
 
Immortalized Sertoli cell lines sk11 and sk9 and binding of spermatids in vitro. 
(In Review)
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ABSTRACT 
 
Current studies of Sertoli cell-germ cell binding dynamics in vitro require the use 
of primary Sertoli cell isolates.  The aim of this study was to determine the effectiveness 
of the sk11, sk9, and sk11 TNUA5 Sertoli cell lines in binding germ cells in vitro.  These 
immortalized cell lines were utilized in coculture experiments with germ cells in media 
with/without reproductive hormones and incubated for 44 h, 32°C.  The number of germ 
cells bound to Sertoli cells was then determined and statistically analyzed.  Western Blot 
analysis and RT-PCR studies were employed to investigate the presence of cell 
adhesion proteins and FSH receptor, respectively.  No statistical difference between the 
number of bound step-8 spermatids and bound pre-step 8 spermatids on Sertoli cells 
from any of the cell lines existed.  After the addition of germ cells, Sertoli cells showed 
more lipid accumulation in their cytoplasm, indicating active phagocytosis.  Western Blot 
analysis in the sk11 TNUA5 line indicated the expression of N-cadherin.  FSH only and 
testosterone only treatments increased N-cadherin expression, regardless of germ cell 
addition.  The addition of germ cells to the sk11 TNUA5 Sertoli cells increased the 
expression of espin, as did the addition of FSH with germ cells.  RT-PCR studies of the 
sk11 TNUA5 cells indicated that the mRNA for FSH receptor decreased with successive 
passages.  In vitro binding between isolated germ cells and sk9, sk11 or sk11 TNUA5 
Sertoli cells, in a manner similar to that when using primary isolated Sertoli cells, is not 
feasible, and therefore these cell lines are not useful for the investigation of Sertoli-germ 
cell interactions.   
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INTRODUCTION 
 
 Spermatogenesis is a complicated process occurring throughout the reproductive 
life of the male.  It is a remarkable process in which germ cells undergo mitosis, meiosis 
and cellular differentiation to produce spermatozoa [1].  At any given point, several 
generations of germ cells develop at the same time in the seminiferous tubule of 
mammals [2].  The seminiferous epithelial cycle is made up of various stages, in which 
new generations of germ cells are connected to older generations, with their 
development coordinated via the presence of fixed cellular associations [2].   
 Occluding junctions, adherens junctions and gap communicating junctions are 
thought to play crucial roles in spermatogenesis.  Not only important in mechanical 
adhesion, the actin-based cell-cell adherens junctions between the Sertoli cell and the 
germ cell in the mammalian testis is also important in the morphogenesis and 
differentiation of the germ cells [3].   During the process of germ cell migration from the 
basal to the adluminal epithelial compartments, these junctions turnover [4].  However, 
their role in complete spermatogenesis is not yet fully understood.  The Sertoli 
ectoplasmic specialization, a cytoskeletal structure of the Sertoli cell, is associated with 
Sertoli-germ cell binding [5,6].  The morphology of testicular junctions has been well 
described, but their molecular composition still is not well understood.  ectoplasmic 
specializations are found basally in the Sertoli cell near Sertoli-Sertoli tight junctions and 
between Sertoli cells and germ cells and consist of hexagonally packed bundles of actin 
filaments situated between the plasma membrane and a cistern of endoplasmic 
reticulum [3].  A reduction of mature sperm in semen has been associated with abnormal 
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or absent Sertoli ectoplasmic specializations [7-11].  To ensure the retention of 
spermatids as they mature into spermatozoa, the ectoplasmic specialization is an 
important cell-cell adhesion mechanism in the seminiferous epithelium.   
 Espin is an actin binding protein found in the testis, specifically the Sertoli cells 
and shows no resemblance to other actin-binding proteins [12].  In the seminiferous 
epithelium, espin appears to be concentrated around the heads of spermatids from mid- 
to late spermiogenesis, as determined by immunoperoxidase immunocytochemistry [13].  
It is also seen near the base of the seminiferous tubules [13].  Sertoli cells surrounding 
step-8 spermatids, where an organized ectoplasmic specialization is first seen, 
demonstrate espin immunostaining in a C-shaped cap near the area where the 
spermatid meets the Sertoli cell [12].  This is not seen around step-7 spermatids [12].  
Nearing spermiation, espin immunostaining near the luminal edge of the seminiferous 
epithelium decreases and then disappears around the time of sperm release [12].  This 
change in localization appears to reflect the disassembly of the ectoplasmic 
specialization [12].  Through immunogold electron microscopy, espin has been localized 
to the parallel bundles of actin filaments present at the ectoplasmic specialization in 
Sertoli cells [13].  A smaller isoform of espin, termed “small espin,” has been seen 
associated with parallel actin bundles found in brush border microvilli in the kidney and 
intestine [14].  This further supports the hypothesis that espin is involved in the bundling 
of actin at the ectoplasmic specialization.   
Reproductive hormones have been shown to play a role in the regulation of 
binding of spermatids at the Sertoli-spermatid junctional complex.  The key regulators of 
spermatogenesis are follicle stimulating hormone (FSH) and testosterone [15-17].  FSH 
is thought to induce the binding competence of the Sertoli cell [18-20], whereas 
testosterone is believed to stimulate the actual binding between the two cell types 
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[18,20-22].  Cameron and Muffly [19] showed maximal binding of round spermatids to 
Sertoli cells in vitro in the presence of FSH and testosterone.  Testosterone is also 
known to promote and maintain the maturation of round to elongated spermatids in the 
rat [23].  The withdrawal of testosterone has shown detachment of round spermatids 
between spermatogenic stages VII and VIII [8], the time when the ectoplasmic 
specialization forms.  
Several Sertoli cell lines have been established from 10-day-old H-2Kb-tsA58 
transgenic mice carrying a temperature inducible SV40 T-antigen, including the sk11 
and sk9 cell line [24,25].  At a culture temperature of 33°C these cells divide, and by 
switching the temperature to 39°C, division stops.  Little is known about the molecular 
phenotype of these cells, however, they have been reported to express mRNAs for a-
inhibin, Steel factor, SGP-2, transferrin, androgen receptor, SF-1 and FSH receptor [25].  
Though the mRNA for the FSH receptor is found in these cells, it was down-regulated 
compared to in vivo levels, and the level of functional FSH receptor protein remains 
unknown.  The sk11 cells were later transfected with human wild type FSH receptor, 
which allowed for continuously active FSH receptor expression [26].  These cells, sk11 
TNUA5, showed a dose-dependent increase in cAMP production when stimulated with 
FSH [26].   
This project was designed to determine the effectiveness of the sk11, sk9, and 
sk11 TNUA5 Sertoli cell lines in binding germ cells in vitro.  To do this, an established 
Sertoli-germ cell coculture system was used [19], and the number of spermatids bound 
to Sertoli cells was determined by morphometric analysis and correlated with the 
hormone treatments.  The ectoplasmic specialization protein espin was also assayed in 
the cocultures by immunocytochemistry and Western blot analysis, as was the cell 
adhesion protein N-cadherin.  It was hypothesized that the sk11 TNUA5 Sertoli cell line 
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would be suitable to study FSH effects on Sertoli-germ cell coculture, as defined in the 
coculture model utilizing primary Sertoli cell isolates [19], and that the sk11 and sk9 cell 
lines would not.
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MATERIALS AND METHODS 
 
Germ cells were isolated from adult male mouse testes and cocultured with the 
immortalized mouse Sertoli cells in the presence of FSH, testosterone (T), and a 
combination of these two reproductive hormones [19].  The number of spermatids bound 
to Sertoli cells was determined by morphometric analysis and correlated with the 
hormone treatments [19].  Espin, N-cadherin, and FSH receptor were also assayed in 
these cocultures.  
Sertoli cell isolation, culture, and pretreatment 
Immortalized mouse sk9, sk11, and sk11 TNUA5 Sertoli cells were cultured on a 
Matrigel®  substrate (BD) in 24-well cell culture trays at either 32ºC or 39ºC, 5% CO2-
95% air and treated with FSH (NIDDK-oFSH-20, AFP7028D, 175xNIH-FSH-S1), T 
(Sigma) or FSH+T 24 h prior to the addition of mouse germ cells.  The culture medium 
was DMEM (high glucose+L-glutamine) supplemented with 10% fetal calf serum (PAA), 
0.01 µl/ml penicillin/streptomycin (Sigma), 0.01 µl/ml antibiotic/antimycotic (Sigma), and 
5 µg/ml Plasmocin (Cayla).  Cultures were not allowed to grow to confluence, since there 
was lack of contact inhibition, and the cells did not maintain a monolayer configuration.   
Mouse germ cell isolation and coculture 
Mouse germ cells were isolated from adult mice using a series of enzymatic 
treatments [0.5 mg/ml collagenase (Sigma) and 0.25 mg/ml trypsin (PAA)] [19,27] and 
then filtered through a 74 µm nylon mesh.  A total of 400 000 mouse germ cells were 
added to the Sertoli cell monocultures and incubated for 44 h at 32ºC, 5% CO2-95% air.  
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Most Sertoli cell cultures were near confluence at the time of plating.  Controls included 
no hormone treated cocultures and germ cells preincubated for 30 min with the various 
hormone treatments before being added to no hormone treated Sertoli cells. 
Germ cell viability and coculture fixation 
Following 44 h of incubation, the cocultures were washed 5 times with warm 
medium, and the viability of the germ cells in the cocultures was estimated using the 
Trypan Blue assay.  Cocultures were fixed with 4% paraformaldehyde for 20 min at room 
temperature.  Cocultures for immunostaining were fixed with ice cold methanol:acetone 
(1:1) for 10 min at -20ºC and then allowed to air dry at room temperature. 
Morphometry and statistics   
Five digital images were taken in a systematic pattern from each well using 20x 
and 40x objectives.  The number of germ cells was determined for each digital image 
using ImageJ.  Germ cells were classified and counted based on size and appearance.  
Means of germ cell numbers for each treatment group for the three Sertoli cells lines 
utilized were statistically analyzed using one-way ANOVA followed by Scheffe’s multiple-
range analysis.   
Immunocytochemistry 
Sk11 TNUA5 Sertoli cell monocultures and Sertoli-germ cell cocultures were 
fixed in methanol:acetone (1:1) for fluorescent immunostaining of the ectoplasmic 
specialization protein espin or fixed in 95% ethanol:5% acetic acid for fluorescent 
immunostaining of the cell adhesion protein N-cadherin.  The fixed cocultures were 
incubated for 1 h at room temperature with espin (10 µg/ml; Transduction Laboratories) 
or anti-N-cadherin (2 µg/ml; Zymed) followed by a 1 h incubation at room temperature 
with Cy3 (1:100; Jackson) as the secondary antibody.  The antibody complex was 
visualized using a fluorescent microscope. 
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Gel electrophoresis and Western blot 
Some Sertoli cell monocultures and Sertoli-germ cell cocultures were collected 
for Western Blot analysis. After 44 h of incubation, the cultures were washed 5 times 
with medium and the cells were lysed using a cell scraper and pooled in the various 
treatment groups.  The protein was extracted using homogenization in Buffer A (10 mM 
HEPES (KOH) pH 7.9, 10 mM KCl, 1 mM DTT, 0.2 mM EDTA, 0.1% NP-40, protease 
inhibitors (Roche “Complete”), 0.5 mM PMSF) or Crash Buffer (1 M Tris HCl pH 6.8, 
20% SDS, 1 M DTT, protease inhibitors (Roche “Complete”), 0.5 M EDTA pH 8).  The 
proteins were separated by SDS-PAGE gel electrophoresis and transferred onto 0.45 
µm PVDF membrane.  The blots were then stained for espin using the espin antibody 
mentioned above (1:1000, 1 h room temperature), followed by a 1 h incubation with Cy5 
(1:500; Jackson).  Membrane bound antibodies were detected using a fluoroimager 
(Storm 860; Molecular Dynamics) with a laser diode and emission filter for Cy5 (650 nm 
– 670 nm).  The image was viewed using Image Quant 5.0 (Molecular Dynamics). 
RNA Isolation 
            Monocultures of sk11 TNUA5 cells were washed once in serum-free medium and 
then lifted using a cell scraper and RNAPure (PeqLab).  The cells were vortexed for 30 
sec and incubated at room temperature for 5 min, after which 600 µl chloroform was 
added and mixed well.  The cell lysate was then centrifuged for 30 min at 4000 rpm, 4ºC.  
The supernatant was collected and added to 1.5 ml isopropanol.  This was then placed 
on a shaker for 1 h at -20ºC, followed by centrifugation for 1 h at 4000 rpm.  The 
supernatant was aspirated and discarded, and the total RNA was then further purified 
using the RNeasy Mini Kit (Qiagen), as per manufacturer’s instructions.  After isolation, 
RNA integrity was assessed using agarose/GITC gels.  The purity was checked by UV-
spectrometry in 10 mM Na2HPO4/NaH2PO4-buffer (pH 7.0). 
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Real-time RT-PCR 
Real-time RT-PCR was used to examine the mRNA expression of FSH receptor, 
N-cadherin and espin in sk11 TNUA5 Sertoli cells and was performed on a LightCycler™ 
instrument (Roche).  cDNA was synthesized from 1000 ng of total RNA using oligo dT(12-
18) (Invitrogen) with Superscript II reverse transcriptase (Invitrogen).  PCR was performed 
using a PCR cocktail containing 10 pmol each gene specific primers (Table 4.1), 2 µl 
dNTP mix (25 mM each; Takara Bio), 0.5 µl SybrGreen I (1:1000 in DMSO; Molecular 
Probes), 0.25 µl BSA (20 mg/ml; Sigma), and 0.2 µl Ex-Taq HS (5 U/µl; Takara Bio) in a 
total volume of 20 µl.  Cycling conditions were as follows: denaturation (95°C for 5 min), 
amplification and quantization (95°C for 10 sec, 60°C for 10 sec, and 72°C for 30 sec, 
with a single fluorescence measurement at the end of the 72°C segment) repeated 40 
times, a melting curve program (60 – 95°C with a heating rate of 0.2°C/sec and 
continuous fluorescence measurement) and a cooling step to 40°C.  The threshold cycle 
(crossing point) in which the fluorescence rises appreciably above background level was 
determined by a second derivate maximum method with the use of the LightCycler™ 
Quantification Software.  For exact comparison of mRNA transcription in the different 
samples the ribosomal gene RPS27a was used as reference gene.  In addition to the 
verification of a single PCR product by the presence of only one melting peak, the PCR 
products were resolved by electrophoresis on a 1% agarose/TAE gel and checked for 
correct molecular size.   
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Table 4.1.  Sequences for real-time RT-PCR primers. 
Sequences for real-time RT-PCR primers 
Gene Sequence TM [ºC] 
RPS27a-5’ CCA GGA TAA GGA AGG AAT TCC TCC TG 64.8 
RPS27a-3’ CCA GCA CCA CAT TCA TCA GAA GG 62.4 
   
FSHR-5’ GTG GTC ATC TGT GGT TGC TAC ACC 64.4 
FSHR-3’ AAG GAT TGG CAC AAG AAT TGA TGG 59.3 
   
N-Cadherin-5’ CTG CCA ACT GGC TGA AAA TAG ACC 62.7 
N-Cadherin-3’ AGT TGG GTT CTG GAG TTT CAC AGG 62.7 
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RESULTS 
 
Three cell lines reported to express mRNA for the FSH receptor – the sk9, sk11, 
and sk11 TNUA5 Sertoli cell lines – were used for Sertoli-germ cell coculture. After the 
addition of germ cells to subconfluent layers of sk9, sk11, and sk11 TNUA5, the lipid 
accumulation in these cells increased (figure not shown), indicating an increase in 
phagocytic activity.  The sk11 cells appeared to contain the most lipids, although this 
was not quantified.  Upon the addition of hormones and germ cells, the sk9 and sk11 
cells reorganized in vitro to form tubule-like aggregates (Figure 4.1).  
  
 
 
 
 
 
 
 
 
 
Figure 4.1.  Light micrograph of tubule formation in vitro by the sk cell lines after the addition of germ cells 
and hormones.  A light micrograph of an example of the tubule formation observed in the sk cell lines 44 h 
after adding germ cells and FSH and testosterone (image taken from sk11 cell line). 
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The number of bound spermatids per hormone treatment can be seen in Table 
4.2.  A one-way ANOVA (p<0.05) determined no significant difference between the 
hormone treatments and number of pre-step-8 spermatids or step-8 spermatids bound to 
Sertoli cells from any of the cell lines.  No difference was seen in the number of bound 
spermatids on Sertoli cells incubated prior to germ cell addition at 32ºC or 39ºC.    
 
Table 4.2.  Total number of spermatids bounds to immortalized mouse Sertoli cells.  Total number of 
spermatids bound to sk9 cells from 7 cocultures (24 well plates), bound to sk11 cells from 5 cocultures (24 
well plates), and bound to sk11 TNUA5 cells from 9 cocultures (24 well plates). 
Total number of spermatids bounds to immortalized mouse Sertoli cells 
sk9 No Hormone FSH T FSH+T 
Pre-step-8 51 38 35 43 
Step-8 19 19 16 18 
sk11 No Hormone FSH T FSH+T 
Pre-step-8 1 0 3 1 
Step-8 1 0 0 2 
sk11 No Hormone FSH T FSH+T 
Pre-step-8 1 2 6 3 
Step-8 3 2 5 5 
 
Since the most promising cell line was thought to be the sk11 TNUA5 line, 
immunocytochemistry and Western Blot was utilized to identify the presence of specific 
proteins involved in cell adhesion and the ectoplasmic specialization.  The expression of 
espin in sk11 TNUA5 cells appeared to increase with the addition of FSH+T, as 
indicated by immunofluorescence staining intensity (Figure 4.2).  Western Blot analysis 
of this protein in these cells is inconclusive.  Immunofluorescence of N-cadherin in the 
sk11 TNUA5 cells has thus far been unsuccessful.  However, via Western Blot analysis, 
N-cadherin was shown to be expressed in the sk11 TNUA5 cell line.  Whereas the FSH 
and T treatments alone appeared to increase N-cadherin expression in these cells, the 
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Figure 4.2.  Fluorescent immunostaining of espin in immortalized mouse rat Sertoli cell-sperm atid cocultures 
plated on Matrigel®.  (A) Sk11 TNUA5 monoculture immunostained for espin.  (B) Sertoli-germ cell coculture 
using sk11 TNUA5 cells. Negative control for espin immunostaining.  (C) Sertoli-germ cell coculture using 
sk11 TNUA5 cells immunostained for espin in the absence of hormones.  (D) Sertoli-germ cell coculture 
using sk11 TNUA5 cells immunostained for espin in the presence of FSH.  (E) Sertoli-germ cell coculture 
using sk11 TNUA5 cells immunostained for espin in the presence of testosterone.  (F) Sertoli-germ cell 
coculture using sk11 TNUA5 cells immunostained for espin in the presence of FSH and testosterone.  
Blue=nucleus.  Red=espin. 
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combination of the two hormones, as well as the addition of germ cells, did not appear to 
affect the expression of this protein (Figure 4.3). 
 
 
 
Figure 4.3.  Immunodetection of espin in Sertoli cell, germ cell and Sertoli-germ cell coculture lysates.  
Western Blot for N-cadherin in sk11 TNUA5 cell cultures.  SC=sk11 TNUA5 Sertoli cells, GC=germ cells, 
M=marker, NoH=no hormone, FSH=follicle stimulating hormone, T=testosterone. 
 
Real-time RT-PCR was used to examine the mRNA expression of FSH receptor 
and N-cadherin in sk11 TNUA5 Sertoli cells in comparison to a control sample (C14 – 
mice testis, day 30).  The crossing points (CP) for FSH receptor and N-cadherin in the 
cell line are shown in table 2.3.  Briefly, the CP for the FSH receptor in sk11 TNUA5 
passage 3 cells is 26.82, whereas in passage 17, it is 28.76, and for N-cadherin, sk11 
TNUA5 passage 3 the CP is 17.79 and 16.22 in passage 17.  The CP is defined as the 
point at which the fluorescence rises appreciably above the background fluorescence 
and is therefore a measure for the mRNA amounts.   
For exact comparison of mRNA levels in the different samples the ribosomal 
gene RPS27a was used as reference gene.  The CP values for the RPS27a show that 
this gene is expressed at a constant level in the sk11 TNUA5 Sertoli cells and in the 
control sample C143 what indicates that there are nearly equal amounts of mRNA 
starting material (Table 4.3).  Figure 4.4 demonstrates the LightCycler PCR results of the 
sk11 TNUA5 Sertoli cells for the FSH receptor (a) and the N-Cadherin gene (b).  
Whereas N-cadherin could be detected, it was not possible to quantify mRNA levels for 
the FSH receptor gene in these cells.  
  117 
Table 4.3.  Crossing points for the FSH receptor and N-cadherin transcripts in the sk11 TNUA5 cell line.  
The crossing points for the investigated genes in the sk11 TNUA5 cells, using Real Time RT-PCR and 
performed on a LightCycler™ instrument. The crossing point is defined as the point at which the 
fluorescence rises appreciably above the background fluorescence and is therefore a measure for the 
mRNA amounts.  FSH-R= FSH receptor; p=passage. 
Crossing points for each transcript 
Cell RPS27a FSH-R N-cadherin 
sk11 TNUA5 p3 10.44 26.82 17.79 
sk11 TNUA5 p17 10.37 28.76 16.22 
sk11 TNUA5 p17 +FSH 10.66 28.93 16.20 
control C143 9.69 22.65 20.71 
 
 
 
 
Figure 4.4.  RT-PCR results for the FSH receptor and N-cadherin genes.  RT-PCR results for sk11 TNUA5 
Sertoli cells and a control (C143) for the FSH receptor (a) and the N-cadherin gene (b).  (c) 1% agarose/TAE 
gel of the RT-PCR products.  M=100 bp molecular weight marker, lane 5 and 10=no cDNA, water control.  
p=passage. 
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DISCUSSION 
 
In vitro studies of the interactions between Sertoli cells and germ cells are time-
consuming and expensive, in that the current established method consists of using 
primary Sertoli cell isolates.  Very few Sertoli cell lines exist and most do not possess the 
receptor for FSH and are therefore insufficient for studying how FSH is involved in the 
binding dynamics between germ cells and Sertoli cells.  The development of a Sertoli 
cell line that expresses functional FSH receptor protein and supports germ cell binding is 
of great interest.  Three cell lines have been reported to express the mRNA for the FSH 
receptor – the sk9, sk11, and sk11 TNUA5 Sertoli cell lines [24-26], all established from 
H-2Kb-tsA58 transgenic mice.  Sneddon et al [28] have demonstrated that the sk11 
Sertoli cell line maintains the Sertoli cell phenotype in relation to androgen and estrogen 
receptors, in that the expressed androgen receptor and estrogen receptor-ß induces 
expression of reporter gene constructs in the presence of a range of steroid ligands [28].  
As a result of these studies, these cells would appear to be good candidates for use in 
Sertoli-spermatid binding studies.   
The accumulation of lipids in the sk9, sk11, and sk11 TNUA5 cells was evident 
following the addition of germ cells, indicating, therefore, the retention of the well-defined 
phagocytic activity of Sertoli cells.  Results from the current study, however, indicate that 
these cell lines have limited value for the investigation of Sertoli-germ cell binding 
dynamics in vitro. 
Although the addition of hormones and germ cells to the sk9 and sk11 cells 
resulted in the formation of tubule-like structures, there was no apparent binding in vitro 
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between these cells and the added germ cells, resulting in an inappropriate membrane 
binding domain for the germ cells [19].  It is also possible that the presence of serum in 
the culture medium, necessary to maintain the viability of the immortalized Sertoli cells, 
inhibited FSH binding and/or receptor activation [29].  This being the case, there would 
not likely be FSH-induction of Sertoli cell binding competency, and therefore an inability 
to bind germ cells [19].  When cultured in medium without serum, but supplemented with 
retinol, insulin, transferrin and selenium, the cells appeared fusiform and not suitable for 
binding studies.  The RT-PCR results indicate that the sk11 TNUA5 Sertoli cells have 
almost non-existent levels of FSH receptor mRNA with each passage, thereby providing 
an explanation for the lack of specific spermatid binding.  This is in contrast to 
Strothmann et al [26], who claim continuous active FSH receptor expression [26] in 
these cells, showing a dose-dependent increase in cAMP production when stimulated 
with FSH [26]. 
With the addition of germ cells, the expression of espin in the sk11 TNUA5 cells, 
as analyzed via immunofluorescence, appeared to increase in the presence of FSH, but 
the organization of this protein appeared to be random.  Still, in the presence of both 
FSH and T, espin appeared to be at the periphery of the Sertoli cells, suggesting that 
this actin binding protein was not involved in cell-cell binding activity in our coculture 
model.   
Via Western Blot analysis, N-cadherin was also detected in the sk11 TNUA5 cell 
line.  Whereas FSH or T treatment alone appeared to increase N-cadherin expression in 
these cells, the combination of the two hormones, as well as the addition of germ cells, 
did not appear to affect the expression of this binding protein. 
Although the sk11 TNUA5 cells were stably transfected with a human FSH 
receptor construct [26], these cells lines have limited value for the investigation in vitro of 
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Sertoli-germ cell binding interactions.  First, the mRNA for the FSH receptor decreases 
in amount with successive passages, so that by passage 17 the message is almost non-
existent.  Second, the actin binding protein espin was expressed with the addition of 
germ cells, appeared to increase in the presence of FSH and became peripheralized in 
the presence of both FSH and T together.  Still, this response was not associated with 
germ cell binding.  Finally, the sk11 TNUA5 Sertoli cell line also expressed the binding 
protein N-cadherin, which appeared enhanced by the presence of either FSH or T alone.  
The combination of these hormones, as well as the addition of germ cells, did not appear 
to affect the expression of this binding protein, and, like espin, was not associated with 
binding of germ cells.  
 Although the sk9 and sk11cells originally expressed mRNA for the FSH receptor, 
and the sk11 TNUA5 cells are thought to have a functional FSH receptor, these cells are 
not useful for in vitro investigation of Sertoli-germ cell interactions.  However, they 
should not be ruled out for in vitro work, such as Sertoli cell biology and/or Sertoli cell 
interactions with non-germ cell types not requiring FSH.   
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It is theorized that spermatids associated with ectoplasmic specializations adhere 
to Sertoli cells more strongly than all other germ cells and that this is essential for 
anchoring spermatids in the seminiferous epithelium during the final stages of 
spermiogenesis.  Additionally, complete spermiogenesis is not observed in the absence 
of these unique Sertoli-spermatid junctions, which when disrupted, lead to spermatid 
sloughing and oligospermia [1-3].  However, the actual junctional strength between 
Sertoli cells and spermatids has never been measured to verify this unsubstantiated 
dogma central to the successful completion of spermatogenesis. 
In this dissertation, for the first time, the actual strength of junctions between 
germ cells and Sertoli cells in vitro has been determined.  The data presented confirm 
the hypothesis that step-8 spermatids are more firmly attached to Sertoli cells than are 
spermatocytes and pre-step-8 spermatids.  Of the cells tested, the ectoplasmic 
specialization is only present between Sertoli cells and step-8 – step-19 spermatids and 
is conspicuously absent between Sertoli cells and spermatocytes and pre-step-8 
spermatids [4]. This suggests that the structural nature of the ectoplasmic specialization 
contributes to the actual junctional strength between these two cell types, ensuring that 
elongating spermatids (post-step-8 spermatids) are securely anchored to the 
seminiferous epithelium during the final stages of spermiogenesis.  This also supports 
the hypothesis that when the ectoplasmic specialization does not form properly between 
the Sertoli cell and the periluminal step-8 spermatid, or is otherwise abnormal, the 
junction strength is significantly lessened, thereby leading to spermatid sloughing and 
oligospermia [5]. 
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Results from this dissertation show that the junctional strength between Sertoli 
cells and germ cells can be measured in vitro, support long held speculations regarding 
Sertoli-spermatid junctional interactions, and provide a means to actually test proposed 
mechanisms of junction dynamics between cells of the seminiferous epithelium. 
One such disruptor of cell junctions in the seminiferous epithelium is Adjudin, 
which is hypothesizes to work at the level of the adherens junction and possibly the 
ectoplasmic specialization, since depletion of round and elongated spermatids is seen in 
rats after administration of this potential male contraceptive [6-8].  This dissertation 
tested the strength of the junction between the step-8 spermatid and the Sertoli cell in 
the presence of Adjudin in vitro.  The data presented confirm the hypothesis that this 
compound, at higher concentrations, disrupts the Sertoli-spermatid junctional complex, 
causing weaker binding between the Sertoli cell and step-8 spermatid.  Though the 
exact protein complex acting as the receptor for Adjudin has not yet been defined, it is 
thought that through various signaling pathways (such as the RhoB activation of ROCK, 
LIMK1, and cofilin [9] and/or the ß1 integrin activation of the FAK/PI 3-
kinase/p130Cas/MAP kinase pathway [10]), changes in the polymerization and 
depolymerization of actin at the ectoplasmic specialization lead to a depletion of germ 
cells from the seminiferous epithelium, in particular round and elongating spermatids [8].  
Results from this dissertation show that the junctional strength between Sertoli cells and 
step-8 spermatids is reduced by Adjudin in vitro, supporting the potential use of this 
chemical as a male contraceptive. 
In vitro studies of the interactions between Sertoli cells and germ cells, such as 
those in the first and third chapters of this dissertation, are difficult and expensive, in that 
the current established method consists of using primary Sertoli cell isolates.  Very few 
Sertoli cell lines exist and most do not possess the receptor for FSH and are therefore 
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insufficient for studying how FSH is involved in the binding dynamics between germ cells 
and Sertoli cells.  The development of a Sertoli cell line that expresses functional FSH 
receptor protein and supports germ cell binding is of great interest.  Three cell lines have 
been reported to express the mRNA for the FSH receptor – the sk9, sk11 and sk11 
TNUA5 Sertoli cell lines [11-13], all established from H-2Kb-tsA58 transgenic mice.  As a 
result of the aforementioned studies and others, these cells would appear to be good 
candidates for use in Sertoli-spermatid binding studies.   
This dissertation explored the potential use of these cells for in vitro Sertoli cell-
spermatid binding studies.  Results indicate that these cell lines have limited value for 
the investigation of Sertoli-germ cell binding dynamics in vitro.  Although the addition of 
hormones and germ cells to the sk9 and sk11 cells resulted in the formation of tubule-
like structures, there was no apparent binding in vitro between these cells and the added 
germ cells, resulting in an inappropriate membrane binding domain for the germ cells 
[14].  It is also possible that the presence of serum in the culture medium, necessary to 
maintain the viability of the immortalized Sertoli cells, inhibited FSH binding and/or 
receptor activation [15].  This being the case, there would not likely be FSH-induction of 
Sertoli cell binding competency, and therefore an inability to bind germ cells [14].  The 
RT-PCR results indicate, however, that the sk11 TNUA5 Sertoli cells have almost non-
existent levels of FSH receptor mRNA with each passage, thereby providing an 
explanation for the lack of specific spermatid binding.  Although the sk11 TNUA5 cells 
were stably transfected with a human FSH receptor construct [13], these cells lines have 
limited value for the investigation in vitro of Sertoli-germ cell binding interactions, as do 
the sk11 and sk9 cell lines.   
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APPENDICES
APPENDIX 1 – HORMONES 
Follicle stimulating hormone 
 Evidence exists for the idea that spermatogenesis can be completed, and that 
fertility is possible, without the presence of FSH.  Although the testis size and sperm 
count are reduced in FSHß subunit knock-out mice, they mature normally sexually and 
fertility is present [1].  The same is seen when the FSH-receptor is disrupted [2, 3].  In 
the human, a mutation of the FSH-receptor results in a reduction of sperm count but 
fertility still remains [4].  Spermatogenesis can be induced and restored by testosterone 
in the absence of FSH, as seen in mice with a GnRH deficiency [5]. 
 However, primate studies have demonstrated a need for FSH in the maintenance 
of spermatogenesis in both the human and the monkey.  Immunization to FSH in the 
monkey and the human induces impairment in sperm production and quality [6, 7].   An 
essential role for FSH in man is further supported by the finding of azoospermia in a man 
with an inactive FSHß subunit [8], which could indicate either the necessity of FSH for 
the testicular development required for spermatogenesis and/or the establishment and 
maintenance of spermatogenesis in the adult.  The requirement of exogenous FSH in 
hypogonadotrophic men in order to establish spermatogenesis identifies the need for 
FSH in the induction of permanent maturational effects on the seminiferous epithelium.   
Androgens 
Testosterone plays a critical role in normal germ cell development and 
maintenance of reproductive potential in the male.  However, it is the function of the 
androgens and androgen receptor (AR) that are vital to sexual differentiation and normal 
spermatogenesis.  The binding of testosterone and dihydrotestosterone (DHT) initiates  
nuclear translocation of the AR-steroid complex, which then regulates the transcriptional 
function of AR [9].  In the human, DHT has an important role in male reproductive tract 
development [10], but in the mouse, there is little importance in development for this  
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hormone [11].  Through autocrine feedback on the Leydig cell, the AR is important in 
regulating the level of testosterone by endocrine effects of GnRH production and 
inhibition of LH synthesis and secretion by the pituitary [12].  For example, humans and 
mice with a hemizygous null mutation in the Ar gene demonstrate 
pseudohermaphroditism and infertility [13, 14], in which an XY individual displays an 
external appearance of a female [14], with an incomplete formed vagina and small, 
abdominal testes with early meiotic arrest [13, 15].  Mice homozygous for a mutation in 
the GnRH gene have considerably lowered serum testosterone levels [5], as well as 
meiotic arrest of spermatogenesis [16].  However, spermatogenesis can be rescued with 
androgen replacement [5], whereas FSH alone fails in doing so [17, 18], supporting the 
idea that it is the androgens, not FSH, that are the major regulators of spermatogenesis.  
Furthermore, classic hormone withdrawal studies in rats also help verify the requirement 
of androgens in spermatogenesis.  Acute, stage-specific regression of the seminiferous 
epithelium occurs when androgens are removed from adult rats by hypophysectomy [19, 
20].  The manifestation of testosterone loss is seen as a loss of mid-stage round and 
elongated spermatids, suggesting androgens affect spermiogenesis and spermiation.  
Loss of mid-stage meiotic spermatocytes is also seen.  With long-term hypophysectomy 
and residual testosterone activity removed, spermatogenesis hardly progresses past 
meiosis [21, 22].  Replacement of FSH has little effect on the recovery of 
spermatogenesis, but replacement of LH or androgens does [19, 23, 24].  Similar results 
are seen with the suppression of GnRH activity [25] and destruction of Leydig cells with 
EDS [21, 26].   
Although androgens have a regulatory positive effect on differentiating germ 
cells, a negative effect of androgens also exists for the differentiation of spermatogonial  
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stem cells.  Studies in humans and rats that have had therapeutic radiation or 
chemotherapy for cancer demonstrate a failure of proliferation/differentiation of 
spermatogonia, but upon treatment with a GnRH agonist or testosterone (both of which 
decrease intratesticular testosterone concentration), the germ cell population was 
enhanced by induced spermatogonial mitotic activity and apoptosis inhibition [27, 28].   
Androgen receptors (AR) are found in the Sertoli cell, peritubular myoid cell and 
the Leydig cell [29].  Androgens are necessary for spermatogenesis, and since the AR is 
not found in the germ cell [29], it is speculated that testosterone works through the 
Sertoli cell, as does FSH.  The concentration of testosterone in the testis is greater than 
that needed to fully saturate the AR.  When this level is reduced experimentally, 
spermatogenesis is interrupted, but at a testosterone concentration far in excess of that 
needed for the maintenance of androgen effects elsewhere in the body [30]. 
Androgen receptor 
AR expression in the testis is limited to the somatic cells (Leydig, peritubular 
myoid, and Sertoli cells) [29, 31-33], but some authors have described the AR in human 
spermatogonia [34], mouse fetal and postnatal germ cells [33], and rat spermatids [31].  
Work with AR-null chimeric mice and from germ cell transplantation studies demonstrate 
that AR in male germ cells is not necessary for normal fertility [35, 36].  Continuous 
expression of AR is seen in Leydig and peritubular cells, while a stage-specific 
expression of AR is seen in the Sertoli cell [29], with testosterone supporting this 
expression [37].  A DHT responsive promoter is also found upstream of the Ar gene [38], 
thereby further illustrating the idea of androgen/AR auto-regulation of AR expression in 
the testis.  Stages VII – VIII of spermatogenesis demonstrate the highest expression of  
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AR in the Sertoli cell, corresponding with the stages most affected by androgen 
withdrawal [19-21].   
Estrogens 
Surprisingly one of the metabolites of testosterone, estradiol (E2), also plays a 
role in the maintenance of fertility in the male, though the effects appear to be secondary 
and indirect.  Estrogens are derivatives of androgens, synthesized by the aromatase 
complex, which contains the cytochrome p450 enzyme (encoded by the cyp19 gene) 
[39].  Though aromatase has been found to be expressed in the Leydig cells [40], 
elongated spermatids [41], immature Sertoli cells [42], and ejaculated spermatozoa [43, 
44], the role of estrogens in spermatogenesis is still not clear. 
Estrogen receptor (ER) a has been detected in the Leydig cells and the 
peritubular myoid cells in the adult rat and mouse testis [33, 45], as well as in the 
efferent ductules [33, 45, 46].  ERß, however, is found in many cell types, including the 
Sertoli cell [47-49], early round spermatids, late spermatocytes [48-50], efferent 
ductules, epididymis, and vas deferens [33, 46, 48, 49].  Within the human testis, there 
has been a failure to immunolocalize ERa [51, 52], but high levels of ERa are found in 
the efferent ductules [53].  In contrast, ERß has been detected in the human testis, with 
the highest level of ERß1 being in round spermatids and the highest level of ERß2 in the 
Sertoli cells [51-53].  Both ERa and ERß bind E2 with high affinity.   
In mouse studies, targeted disruptions of the ER receptors have been 
undertaken in order to study the effect of estrogens on reproductive function (knock-out 
models: ERaKO, ERßKO, and ERaßKO) [54-56].  Aromatase knockout mice (ArKO) 
have also been created by knocking out Cyp19 [57].  Other studies have used knockout  
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mice for estrogen sulfotransferase enzymes [58] and the administration of anti-estrogens 
[59-61].   
Studies of ERaKO mice demonstrate a decline in testicular function in the adult, 
due to a pressure build-up in the seminiferous tubules as a result of impairment of fluid 
absorption in the efferent ductules [46].  Germ cell maturation does not require ERa; 
germ cells transplanted from ERaKO mice produce sperm capable of fertilizing eggs 
[62].  ERßKO mice have no disruption of testicular function or fertility [54].  ArKO male 
mice are unable to convert C19 steroids (androgens) to C18 steroids (estrogens) and 
exhibit disrupted spermatogenesis as they develop, with the specific defect in spermatid 
development, manifested as spermatogeneic arrest at early spermiogenesis and 
increased apoptosis [63, 64].  A large number of round spermatids are found in the 
semen (spermatid sloughing) of ArKO mice, indicating that the conversion of 
testosterone to estrogen may be necessary for the formation of the Sertoli-spermatid 
junctional complex [63].   
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APPENDIX 2 – IMMORTALIZED SERTOLI CELL LINES 
 
Currently, the best way to obtain Sertoli cells for in vitro studies is via primary 
isolation.  Although this method is very effective, it can also cause a delay in 
investigation, since several hours are lost during the isolation.  Moreover, use of an 
established cell line could effectively and immensely assist research Sertoli cells 
function.  Currently several lines exist, including the widely used TM4 cells from the 
mouse [1].  Other cell lines that have been established are the mouse Sertoli cell 1 
(MSC-1) [2], 15P-1 (mouse) [3], 45T-1 (mouse) [3], 42GPA-9 (mouse) [4], SF-7 (mouse) 
[5], TR-ST (rat) [6], ASC-17D (rat) [7], and the TTE-3 (mouse) [8].  Many other Sertoli 
cell lines have been established, but little has been reported on them.  None of these cell 
lines have been suitable for the study of Sertoli cell-spermatid interactions, mainly due to 
a lack of FSH-receptor expression. 
Several Sertoli cell lines (labeled sk) have been established from 10-day-old H-
2Kb-tsA58 transgenic mice carrying a temperature inducible SV40 T-antigen and exhibit 
a genetic phenotype like those in vivo [9, 10].  As a result of this antigen, these cells 
divide at a culture temperature of 33°C and stop division at a temperature of 39°C [9].  
Within two days at the higher, nonpermissive temperature, a change in cell morphology 
is observed [9].  No indication of massive apoptosis is apparent in the culture [9].  When 
returned to the lower, permissive temperature, the cells resume the morphology of 
dividing cells and proliferate [9].  Protein synthesis is not affected by the shift to the 
nonpermissive temperature [9].   
Little is known about the molecular phenotype of these cells.  However, they 
have been reported to express mRNAs for a-inhibin, Steel factor, sulfated glycoprotein-
2, transferrin, androgen receptor, GATA-1, and FSH-receptor [9, 10].  
Immunocytoskeletal analysis of cytoskeletal proteins demonstrated the presence of a- 
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smooth muscle actin, neurofilament protein 200, and vimentin in a pattern exactly 
corresponding to that of Sertoli cells in vivo [9], indicating further that these cells are of 
Sertoli cell origin.  Although the mRNA for the FSH-receptor was found in these cells, it 
was down-regulated compared to in vivo levels, and the level of functional FSH-receptor 
protein remains unknown.  Sneddon et al [11] have demonstrated that the sk11 Sertoli 
cell line (one of the sk cell lines) maintains the Sertoli cell phenotype in relation to 
androgen and estrogen receptors, in that the expressed AR and ERß induced 
expression of reporter gene constructs in the presence of a range of steroid ligands [11].  
These sk11 cells were later transfected with human wild type FSH-receptor, which 
allowed for continuously active FSH-receptor expression [12].  These cells, sk11 
TNUA5, showed a dose-dependent increase in cAMP production when stimulated with 
FSH [12].  These cells may provide a possible alternative to primary isolations in Sertoli 
cell studies in vitro. 
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